Introduction {#s1}
============

Macroautophagy (hereafter referred to as autophagy) is a multistep cellular recycling process in which cytosolic components are encapsulated in membrane vesicles and ultimately degraded in the lysosome. Multiple autophagy (*ATG*) genes are involved in the initial formation of a crescent-shaped double-membrane vesicle called the phagophore or isolation membrane (IM), which elongates and engulfs cytosolic cargo, forming the autophagosome (AP). APs then fuse with lysosomes to form autolysosomes (AL), where degradation of cargo takes place ([@bib45]).

As interest in this pathway and its pathophysiological roles has increased, it has become clear that measurement of autophagic vesicle levels at steady state, without monitoring the overall pathway flux, can lead to controversial results. Autophagy is commonly monitored by enumerating APs under steady-state conditions, also referred to as the AP pool size ([@bib40]), using a GFP-tagged Atg8 marker. During AP formation, Atg8 is cleaved, conjugated to phosphatidylethanolamine, and inserted into the vesicle membrane, thus serving as a marker for IMs and APs ([@bib30]). However, GFP-Atg8 only reports on the size of the IM and AP pools, not the rate by which IMs and APs are formed, or converted to ALs. For example, an increase in the number of GFP-Atg8 punctae could result from increased formation of APs or blockade of the downstream steps. A tandem-tagged mCherry-GFP-Atg8 reporter, which monitors both IMs/APs (yellow \[green/red\] punctae) and ALs (red punctae due to GFP fluorescence quenching in the acidic autolysosome environment) can help distinguish between these possibilities ([@bib29]). We acknowledge that APs can also fuse with acidic endosomes and give rise to amphisomes, which are similarly highlighted as red punctae, and which ultimately fuse with lysosomes to form ALs ([@bib15]). Specifically, when used in combination with chemical inhibitors of autophagy, such as Bafilomycin A (BafA), tandem-tagged reporters can assess autophagic activity in so called autophagic flux assays ([@bib30]). Although tandem-tagged Atg8 markers have been used extensively to monitor autophagy in mammalian cells ([@bib30]), as well as in adult *Drosophila melanogaster* and in *Caenorhabditis elegans* embryos ([@bib42]; [@bib41]), this reporter has not previously been used in adult *C. elegans*, and no comprehensive spatial or temporal analyses of autophagic activity have been reported in any animal thus far.

Autophagy plays important roles in numerous cellular processes and has been linked to normal physiological aging as well as the development of age-related diseases ([@bib37]). Furthermore, accumulating evidence in long-lived species demonstrates that autophagy genes are required for extended longevity. In particular, autophagy is essential for lifespan extension by inhibition of the nutrient sensor mTOR in *Saccharomyces cerevisiae*, *C. elegans*, and *D. melanogaster* ([@bib14]; [@bib36]). In *C. elegans*, autophagy genes are also required for the long lifespan induced by other conserved longevity paradigms, such as reduced insulin/IGF-1 signaling, germline ablation, and reduced mitochondrial respiration, and all these longevity mutants have increased transcript levels of several autophagy genes ([@bib36]). Conversely, neuronal overexpression of *Atg1* or *Atg8* in *D. melanogaster* ([@bib3]; [@bib52]; [@bib53]) or ubiquitous overexpression of *ATG5* in mice ([@bib49]) is sufficient to extend lifespan. Consistent with these findings, all long-lived *C. elegans* mutants examined to date display elevated numbers of GFP::Atg8-positive punctae in their hypodermis during larval development and/or in their intestine during early adulthood ([@bib18]). Long-lived *D. melanogaster* overexpressing Atg1 in neurons also have more GFP::Atg8-positive punctae in neurons and in the intestine than do control animals ([@bib53]). Thus, it has been proposed, but not proven, that autophagic activity is elevated in long-lived animals and that this increase is critical for lifespan extension.

Considerable evidence suggests that autophagic activity changes with age, but it is unclear whether increases or decreases in autophagy are causally related to age-associated impairment of cellular function and organismal health. Aging rats have been shown to have reduced lysosomal proteolysis in liver lysates, and reduced autophagic activity in the liver as assessed by electron microscopy and flux assays ([@bib9], [@bib11]). Moreover, aging is accompanied by a decrease in several autophagy gene transcripts in both *D. melanogaster* ([@bib10]; [@bib39]; [@bib52]) and in rodent tissues ([@bib7]; [@bib54]; [@bib56]; [@bib27]), as well as with a decrease in lysosomal protease activity in *C. elegans* ([@bib51]). In contrast, a recent study proposed that autophagic activity is increased in multiple tissues of *C. elegans* with age, as measured by a fluorescently labeled Atg8 reporter protein containing a lysosomal hydrolase-cleavable linker ([@bib6]). However, this steady-state assay did not conclusively evaluate autophagic activity, and the precise step in the autophagic process marked by the reporter was not identified. Taken together, these observations demonstrate a need for additional assays to evaluate and quantify tissue- and age-specific changes in autophagic activity.

To better understand how aging affects autophagy in *C. elegans*, we employed a GFP-tagged and a novel tandem-tagged (mCherry/GFP) form of LGG-1 (a *C. elegans* ortholog of Atg8) to investigate the spatial and temporal autophagy landscape in wild-type (WT) and long-lived *daf-2* insulin/IGF-1 receptor mutants and germline-less *glp-1* animals. To estimate IM/AP (hereafter referred to as AP) and AL pool sizes, we quantified these LGG-1/Atg8 reporters in the intestine, body-wall muscle, pharynx, and nerve-ring neurons between Day 1 and Day 10 of adulthood. We also performed flux assays (i.e. carried out analyses in BafA-injected animals) to assess autophagic activity in each tissue. Our data indicate that WT animals displayed an age-dependent increase in AP and AL numbers in all tissues, which flux assays suggest reflects a decrease in autophagic activity over time. In contrast, *daf-2* and *glp-1* mutants showed unique age- and tissue-specific differences consistent with select tissues displaying elevated, and in one case possibly reduced autophagic activity compared with WT animals. Moreover, tissue-specific inhibition of autophagy in the intestine significantly reduced the long lifespan of *glp-1* mutants but not of *daf-2* mutants, suggesting that autophagy in the intestine of *daf-2* mutants may be dispensable for lifespan extension. Our study represents the first efforts to comprehensively analyze autophagic activity in a spatiotemporal manner of a live organism and provides evidence for an age-dependent decline in autophagic activity, and for a complex spatiotemporal regulation of autophagy in long-lived *daf-2* and *glp-1* mutants.

Results {#s2}
=======

Spatiotemporal analysis of the GFP::LGG-1 reporter in adult *C. elegans* {#s2-1}
------------------------------------------------------------------------

To perform an in-depth analysis of autophagy in adult *C. elegans*, we used previously published GFP::LGG-1 reporters ([@bib43]; [@bib26]; [@bib13]) to assess the isolation membrane (IM) and autophagosome (AP) pool size (for simplicity referred to as AP pool size, [Figure 1A](#fig1){ref-type="fig"}) in multiple somatic tissues of adult WT animals during aging, including the intestine ([Figure 1B](#fig1){ref-type="fig"}), body-wall muscle (hereafter referred to as muscle; [Figure 1C](#fig1){ref-type="fig"}), pharynx (the foregut of the animal; [Figure 1D](#fig1){ref-type="fig"}), as well as nerve-ring neurons (hereafter referred to as neurons; [Figure 1E](#fig1){ref-type="fig"}). Specifically, we used confocal microscopy and counted the number of GFP::LGG-1 positive punctae in each of these tissues from the first day of adulthood (i.e. when animals become reproductively active) until Day 10 of adulthood ([Figure 1F--I](#fig1){ref-type="fig"}), at which time GFP::LGG-1-positive punctae could still be identified in these major tissues ([Figure 1B'--E'](#fig1){ref-type="fig"}). Notably, all tissues examined showed an increase in GFP::LGG-1-positive punctae over time with the muscle showing the largest (\~9-fold) increase ([Figure 1F--I](#fig1){ref-type="fig"}). We confirmed that the GFP::LGG-1-positive punctae likely represented APs and not GFP::LGG-1 aggregates, since WT *C. elegans* expressing a mutant form of GFP-tagged LGG-1/Atg8 protein (G116A) that is expected to be defective in lipidation and autophagosome-membrane targeting ([@bib41]) showed no punctae formation in the intestine or muscle, and only a small increase in the pharynx over this 10-day time period ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, see figure legend for comment on neurons, which have yet to be evaluated in detail). Taken together, these experiments show that the GFP::LGG-1 reporter can be used to monitor autophagic events in multiple somatic tissues well into old age (i.e. at least until Day 10), and indicate that the AP pool size generally increases over time without forming lipidation-independent aggregates in WT animals. However, these observations are insufficient to evaluate whether the observed increase in GFP::LGG-1-positive punctae represents an induction in the formation, or a block in the turnover of APs.10.7554/eLife.18459.002Figure 1.The autophagosome pool size increases with age in *C. elegans*.(**A**) Schematic representation of GFP::LGG-1 fluorescence states in the autophagy pathway. IM, isolation membrane; AP, autophagosome; AL, autolysosome. (**B--E'**) Adult transgenic WT animals expressing *gfp::lgg-1,* imaged at Day 1 (**B--E**) and Day 10 (**B'--E'**) of adulthood. APs (arrows) can be seen in the intestine (**B,B'**), body-wall muscle (**C,C'**), pharynx (**D,D'**), and nerve-ring neurons (**E,E'**). Dotted lines outline individual intestinal cells (**B,B'**) and pharyngeal bulbs (**D--E'**). AB, anterior pharyngeal bulb; TB, terminal pharyngeal bulb. Scale bars = 20 µm. (**F--I**) Quantification of autophagosomes (AP; GFP punctae) in the intestine (**F**), body-wall muscle (**G**), pharynx (**H**), and nerve-ring neurons (**I**) at Days 1, 3, 5, 7, or 10 of adulthood in WT animals. Day 7 was omitted for neurons due to a counting issue at this time point. Data are the mean ± SEM of ≥20 animals combined from three independent experiments per time point. \#\#\#p\<0.00 and \#\#p\<0.001 for WT control at Day 1, 3, 5, 7, or 10 vs. WT control at Day 1 by Poisson regression.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.002](10.7554/eLife.18459.002)10.7554/eLife.18459.003Figure 1---figure supplement 1.Age-related increase in autophagosome pool size requires lipidation of LGG-1.(**A--C**) Adult transgenic wild-type (WT) animals expressing *gfp::lgg-1(G116A)* imaged at Day 1 (**A--C**) and 10 (**A'--C'**) of adulthood in the intestine (**A**), body-wall muscle (**B**) and pharynx (**C**). Scale bars = 150 µm (**A**), 20 µm (**B**) and 50 μM (**C**). (**D--E**) Quantification of GFP-positive punctae in the intestine, body-wall muscle, and pharynx of WT or *daf-2(e1370)* animals expressing either *gfp::lgg-1* (LGG-1) or *gfp::lgg-1(G116A)* (LGG-1(G116A)) and raised at 20°C (**D**), or WT or *glp-1(e2141)* animals expressing either *gfp::lgg-1* or *gfp::lgg-1(G116A)* (**E**) and raised at 25°C until Day 1 of adulthood and then grown at 20°C for remainder of life. Data are the mean ± SEM of combined from two independent experiments per time point with ≥20 animals total. Two additional repeats of WT animals showed similar results (data not shown). ^∧^, WT + control vs. *glp-1*/*daf-2* control at Days 1, 3, 5, 7, and 10; \*, *glp-1*/*daf-2* control vs. WT/*glp-1*/*daf-2* + BafA at Days 1, 3, 5, 7, and 10, ^\#^, WT/*glp-1*/*daf-2* control at Days 3, 5, 7, and 10 vs. WT/*glp-1*/*daf-2* control at Day 1. \*\*\*/^∧∧∧^/^\#\#\#^p\<0.0001, \*\*/^∧∧^/^\#\#^p\<0.001, \*/^∧^/^\#^p\<0.01 by two-way ANOVA. We note that the pharyngeal counts in WT animals were lower in these experiments compared to others ([Figures 3](#fig3){ref-type="fig"}--[5](#fig5){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}); this may be due to the use of different microscopes, strains, and/or experimenters. We note that we also assessed the number of GFP-positive punctae between and near the pharyngeal bulbs to possibly evaluate neurons; however, while we observed very few punctae in this area in animals expressing GFP::LGG-1(G116A) (data not shown), none of the LGG-1 reporters expressed from the endogenous promoter allowed for accurate cell identification, and neurons therefore remain to be fully evaluated.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.003](10.7554/eLife.18459.003)

Expression of an mCherry::GFP::LGG-1 reporter in adult *C. elegans* {#s2-2}
-------------------------------------------------------------------

To expand our spatiotemporal analysis, we constructed and expressed a dual-fluorescent mCherry::GFP::LGG-1 protein to monitor both APs as well as autolysosomes (ALs), as originally done in mammalian cells ([@bib29]). With this reporter, APs are visualized as punctae positive for both GFP and mCherry fluorescence, while ALs (and amphisomes, for simplicity referred to here as ALs) emit only the mCherry signal due to quenching of GFP in the acidic environment ([Figure 2A](#fig2){ref-type="fig"}). Expression of *mcherry::gfp::lgg-1* from the endogenous *lgg-1* promoter produced a full-length mCherry::GFP::LGG-1 protein ([Figure 2---figure supplement 1A--C](#fig2s1){ref-type="fig"}) that was functional since it was able to rescue an embryonic lethal *lgg-1(tm3489)* mutant (see Materials and methods, data not shown), as previously shown for GFP::LGG-1 expressed from the *lgg-1* promoter ([@bib41]). mCherry::GFP::LGG-1 was expressed in several major tissues of adult WT animals ([Figure 2B--G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--E](#fig2s2){ref-type="fig"}), consistent with the expression profile of GFP::LGG-1 ([Figure 1B--E](#fig1){ref-type="fig"} and \[[@bib43]\]). As previously done for GFP::LGG-1 ([@bib13]), we also expressed mCherry::GFP::LGG-1 from a pan-neuronal *rgef-1* promoter to specifically visualize neurons ([Figure 2G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}). mCherry/GFP double-labeled and mCherry single-labeled punctae were observed in multiple tissues, including hypodermal seam cells, the tissue most commonly characterized thus far when assessing autophagy in *C. elegans* ([@bib18]; [@bib57]), the intestine, muscle, pharynx, and neurons of Day 1 adult animals ([Figure 2C--G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--E](#fig2s2){ref-type="fig"}). Immunofluorescence analysis of the intestine of Day 1 mCherry::GFP::LGG-1-expressing animals showed that both GFP- and mCherry-positive punctae co-localized with structures stained by an LGG-1 antibody ([Figure 2---figure supplement 1D--E](#fig2s1){ref-type="fig"}), consistent with only full-length protein being present in double-labeled punctae. As observed with the GFP::LGG-1 reporter ([Figure 1B'--E'](#fig1){ref-type="fig"}), mCherry/GFP and mCherry-only punctae were observed in *mCherry::gfp::lgg-1* transgenic animals at least until Day 10 ([Figure 2D'--G'](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2B'--E'](#fig2s2){ref-type="fig"}). Hypodermal seam cells could not be visualized in older animals because they fuse and appear as a single line shortly after Day 1 of adulthood. Taken together, these data confirm that transgenic *C. elegans* express an mCherry::GFP::LGG-1 protein that localizes to dual- and single-fluorescent punctae in young and old adults.10.7554/eLife.18459.004Figure 2.Expression and validation of a novel *mCherry::gfp::lgg-1* reporter in *C. elegans*.(**A**) Schematic representation of mCherry::GFP::LGG-1 fluorescence states in the autophagy pathway. IM, isolation membrane; AP, autophagosome; AL, autolysosome. (**B**) Whole-body expression of mCherry::GFP::LGG-1 in a wild-type (WT) animal at Day 1 of adulthood. Scale bar = 100 µm. Note that the intensity of red fluorescence compared to green is stronger; thus, the red channel was purposely set lower (see Materials and methods). (**C--G'**) Adult transgenic WT animals expressing *mCherry::gfp::lgg-1,* imaged at Day 1 (**C--G**) or Day 10 (**D'--G'**) of adulthood. APs (mCherry/GFP; yellow arrowheads) and ALs (mCherry only; white arrowheads) can be seen in the hypodermal seam cells (**C**), intestine (**D,D'**), body-wall muscle (**E,E'**), pharynx (**F,F'**), and nerve-ring neurons (**G,G'**). Dotted lines outline individual intestinal cells (**D,D'**) and pharyngeal bulbs (**F,G'**). AB, anterior pharyngeal bulb; TB, terminal pharyngeal bulb. Scale bars = 20 µm (**D--G'**) and (**C**) = 10 μm. (**H**) Intestine of Day 1 WT transgenic animals expressing *mCherry::gfp::lgg-1* (green, GFP; red, mCherry) and stained with LysoTracker (light blue). Scale bar = 5 µm. (**I**) Quantification of punctae containing mCherry alone or co-localized with GFP or LysoTracker in the intestine of WT transgenic animals. Data are representative of three independent experiments, each with ≥10 animals. (**J**) Schematic representation of basal AP and AL pool sizes and the effect of inhibiting autophagy by *rab-7* RNAi or Bafilomycin (BafA) treatment. (**K**) Quantification of APs and ALs in the intestine of Day 1 WT transgenic animals fed from hatching with bacteria expressing empty vector (control) or dsRNA encoding *rab-7*. Data are the mean ± SEM of ≥40 animals combined from three experiments. \*\*\*p\<0.0001 by Student's *t*-test. (**L**) Quantification of APs and ALs in the hypodermal seam cells of Day 1 WT transgenic animals injected with BafA or DMSO (control). Data are the mean ± SEM of ≥30 animals combined from three experiments. \*\*\*p\<0.0001 and \*\*p\<0.001 by Student's *t*-test.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.004](10.7554/eLife.18459.004)10.7554/eLife.18459.005Figure 2---figure supplement 1.mCherry::GFP::LGG-1 reporter produces a full-length protein.(**A--C**) Immunoblot analysis of lysates from Day 1 transgenic animals expressing *mCherry::gfp::lgg-1* or *gfp::lgg-1.* Blots were probed with anti-LGG-1 (**A**), anti-mCherry (**B**), and anti-GFP (**C**) antibodies. Data are representative of at least two experiments. The lower band of the mCherry::GFP::LGG-1 reporter (\*) may be due to cleavage of the N-terminus as it has previously been published that the first 11 amino acids of mCherry are susceptible to cleavage resulting in something that is slightly smaller than the full length protein ([@bib22]). (**D--E**) Immunofluorescence to detect endogenous LGG-1 (green) and GFP (D; red) or mCherry (E; red) in dissected intestines of wild-type (WT) animals. Data are representative of at least two independent experiments, each with ≥5 animals. Scale bars = 20 µm. Full-length protein was detected at Day 10 (data not shown).**DOI:** [http://dx.doi.org/10.7554/eLife.18459.005](10.7554/eLife.18459.005)10.7554/eLife.18459.006Figure 2---figure supplement 2.mCherry::GFP::LGG-1 reporter is expressed in multiple tissues.(**A--E'**) GFP (green) and mCherry (red) fluorescence images from Day 1 (**A--E**) and Day 10 (**B'--E'**) adult wild-type (WT) transgenic animals expressing the *mCherry::gfp::lgg-1* reporter. The merged images are shown in [Figure 2](#fig2){ref-type="fig"}. Tissues tested were hypodermal seam cells (**A**), intestine (**B,B'**), body-wall muscle (**C,C'**), pharynx (**D,D'**), and nerve-ring neurons (**E,E'**). Autophagosomes (AP, mCherry/GFP) are indicated by yellow arrowheads, and autolysosomes (AL, mCherry only) are indicated by white arrowheads. (**F--I'**) Confocal images of animals with tissue-specific expression of *gfp::lgg-1* in the intestine (**F,F'**), body-wall muscle (**G,G'**), pharynx (**H,H'**), and nerve-ring neurons (**I,I'**) at Day 1 (**F--I**) and Day 10 (**F'--I'**) of adulthood. Arrows indicate APs (GFP punctae). Dotted lines outline individual intestinal cells (**B,B',F,F'**) and pharyngeal bulbs (**D,D',E,E',H,H',I,I'**). AB, anterior pharyngeal bulb; TB, terminal pharyngeal bulb. Scale bars = 20 µm except in (**A**) = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.006](10.7554/eLife.18459.006)10.7554/eLife.18459.007Figure 2---figure supplement 3.Calculations showing that quantification of autophagic vesicles at steady state provide insufficient information to determine autophagic flux.(**A**) Schematic of the autophagy steps with rate constants α, β, and γ. IM, isolation membrane; AP, autophagosome; AL, autolysosome; L, lysosome. (**B**) Definition of autophagic flux at steady state. The rate of AP formation (*dAP/dt*) and AL formation (*dAL/dt*) at steady state is equal to 0 allowing for derivation of equations (1) -- (3) for AP pool size (\[AP\]) and AL pool size (\[AL\]). The overall autophagic flux ('FLUX') at steady state is equivalent to the rates of the individual autophagy steps (equation (4)). (**C**) Derivation of the relationship between rate constants β and γ and the ratio of AP to AL based on the observation made in this study that \[AP\] \< \[AL\] in *C. elegans* ([Figure 3](#fig3){ref-type="fig"}). We used the steady-state equations derived in (**B**). Since AP and AL pool sizes were quantified using the same tissues from animals of the same genotype and age, \[IM\] and α are equivalent for equations (1) and (3). Thus, the ratio \[AP\]:\[AL\] is inversely related to the ratio of the rate constants γ:β, suggesting that γ \< β (equation (5)). (**D**) Relative β and γ rates following Bafilomycin A (BafA) treatment (β~BafA~ and γ~BafA~) compared with control treatment (β~control~ and γ~control~) can be calculated using equations (1) -- (3) derived from steady-state conditions in (**B**). \[IM\] and α are assumed to be constant in control and BafA-treated animals since AP and AL pool sizes were quantified using animals of the same genotype and age. β~BafA~ and γ~BafA~ are inversely related to the change in AP or AL number following BafA treatment (equation 6). Thus, a hypothetical threefold increase in APs and twofold increase in ALs suggests a corresponding threefold decrease in β~BafA~ and twofold decrease in γ~BafA~, demonstrating that BafA inhibits both the AP to AL step and the AL to degradation step, as indicated in the diagram. (**E**) Hypothetical calculation of rate constants. In WT animals, we arbitrarily set the rate of autophagic flux (i.e. \[IM\]α) to 12). In *daf-2* mutants, we envisioned three scenarios: (1) no change in flux, where \[IM\]α = 12, similar to WT, (2) a hypothetical twofold increase in flux where \[IM\]α = 24, and (3) a twofold decrease in flux where \[IM\]α = 6. We then used our observed AP and AL data from WT animals and *daf-2* mutants expressing the mCherry::GFP::LGG-1 reporter (red numbers) to show that different rate constants β and γ (blue numbers) can be calculated for each scenario using the flux equation in (**B**). Thus, it is necessary to quantify the individual rates (i.e. \[IM\]α, \[AP\]β, or \[AL\]γ) or the rate of overall autophagic degradation to determine autophagic flux. The same conclusion can be reached by solving the equations in (**B**).**DOI:** [http://dx.doi.org/10.7554/eLife.18459.007](10.7554/eLife.18459.007)10.7554/eLife.18459.008Figure 2---figure supplement 4.Additional validation of new mCherry::GFP::LGG-1 reporter.(**A,B**) Fluorescence microscopy of wild-type (WT) animals expressing *mCherry::gfp::lgg-1* treated with LysoTracker and injected with DMSO (control) (**A**) or Bafilomycin A (BafA) (**B**) at Day 1 (D1) of adulthood. White arrowhead, mCherry/LysoTracker punctae; yellow arrowhead, mCherry/GFP punctae. (**C**) Quantification of autophagosomes (AP, mCherry/GFP punctae) and autolysosomes (AL, mCherry-only punctae) in hypodermal seam cells of transgenic WT or *cst-1(tm1900)* animals expressing *mCherry::gfp::lgg-1* and injected with DMSO (control) or BafA. Data are the mean ± SEM of ≥35 animals combined from two experiments. \*\*\*p\<0.0001 and \*\*p\<0.001 by one-way ANOVA. (**D**) Quantification of punctae containing mCherry alone or co-localized with GFP or LysoTracker in the intestine of Day 1 WT (data from [Figure 2](#fig2){ref-type="fig"}) and *daf-2(e1730)* transgenic animals raised at 20°C or Day 1 WT and *glp-1(e2141)* transgenic animals raised at 25°C. Data are representative of three independent experiments, each with ≥10 animals.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.008](10.7554/eLife.18459.008)

mCherry/GFP and mCherry-only punctae represent autophagosomes and autolysosomes, respectively, in mCherry::GFP::LGG-1 transgenic animals {#s2-3}
----------------------------------------------------------------------------------------------------------------------------------------

We sought to verify that the mCherry/GFP and mCherry-only punctae observed in mCherry::GFP::LGG-1-expressing animals represented *bona fide* autophagic vesicles. Irrespective of tissue type, the mCherry/GFP-positive punctae ([Figure 2D--G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2B--E](#fig2s2){ref-type="fig"}) were similar in morphology and number to the GFP-positive punctae observed in transgenic animals expressing GFP::LGG-1 ([Figure 1B--E](#fig1){ref-type="fig"} and \[[@bib43]\]), supporting their identity as APs. To determine whether mCherry-only punctae represent ALs, we examined their co-localization with LysoTracker, a pH-sensitive dye that fluoresces in acidic compartments ([@bib21]). Indeed, \~75% of mCherry-positive punctae in the intestine of Day 1 adult WT animals co-localized with LysoTracker and \~10% co-localized with GFP ([Figure 2H--I](#fig2){ref-type="fig"}) consistent with labeling of ALs and APs, respectively. Of note, \~15% of mCherry-positive puncta co-localized with neither GFP nor LysoTracker ([Figure 2H--I](#fig2){ref-type="fig"}). These mCherry-only punctae may reflect inefficient labeling of Lysotracker in the intestine (which was highly variable between animals and experiments, data not shown), or they could represent mCherry aggregates rather than autophagic vesicles; however, we did not observe free mCherry on Western blots ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). While we cannot rule out that this relatively low percentage of mCherry-positive punctae in the intestine could represent aggregates, our data are consistent with the mCherry::GFP::LGG-1 reporter being able to distinguish between APs and ALs in adult *C. elegans*, at least in the intestine of the animal. Hereafter, we will refer to mCherry/GFP and mCherry-only punctae as APs and ALs, respectively. Interestingly, ALs were more abundant than APs in all tissues of WT transgenic animals ([Figure 2D--G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--E](#fig2s2){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}), suggesting that turnover of APs (i.e. formation of APs and conversion to ALs) is faster than turnover of ALs. If so, this would indicate that AL turnover may be rate limiting in *C. elegans* (further addressed in the Discussion; see also [Figure 2---figure supplement 3A--C](#fig2s3){ref-type="fig"}).10.7554/eLife.18459.009Figure 3.The pool size of autophagic vesicles increases with age in all tissues of wild-type animals.(**A--D**) Quantification of autophagosomes (AP) and autolysosomes (AL) in adult Days 1, 3, 5, 7, and 10 wild-type (WT) transgenic animals expressing *mCherry::gfp::lgg-1* and injected with DMSO (control, black lines) or Bafilomycin A (BafA, gray lines). Tissues examined were the intestine (**A**), body-wall muscle (**B**), pharynx (**C**), and nerve-ring neurons (**D**). WT animals were raised at 25°C and incubated at 20°C from Day 1 of adulthood. Data are the mean ± SEM of ≥30 animals combined from three independent experiments per time point. \*\*\*p\<0.0001, \*\*p\<0.001, and \*p\<0.01 for WT control vs WT + BafA on each day; \#\#\#p\<0.0001 for WT control at Days 1, 3, 5, 7, or 10 vs. WT control at Day 1 by Poisson regression.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.009](10.7554/eLife.18459.009)10.7554/eLife.18459.010Figure 3---figure supplement 1.Quantification of autophagosomes at different time points after Bafilomycin A treatment and at different temperatures.(**A--D**) Quantification of autophagosomes (AP) in the intestine (**A**), body-wall muscle (**B**), pharynx (**C**), and nerve-ring neurons (**D**) of Day 1 wild-type (WT) animals expressing *gfp::lgg-1* and analyzed at two hours or 24 hours after injection of DMSO (control) or Bafilomycin A (BafA). Data are the mean ± SEM of 15 animals combined from two experiments \*\*\*p\<0.0001, \*\*p\<0.001, \*p\<0.01 by ANOVA. We note that the BafA treatments in the pharynx were negative in this data set; while other 2 hours incubations caused changes in pharyngeal tissues of WT animals at this and other time points, the response to BafA may be more variable in the pharynx. (**E--H**) Eggs of WT transgenic animals expressing *mCherry::gfp::lgg-1* were allowed to hatch at 20°C overnight and left at 20°C or incubated at 25°C until Day 1 of adulthood. Animals were then moved to 20°C for the rest of their lifespans. Animals were imaged at Day 1 or Day 3 of adulthood. APs (mCherry/GFP punctae) and ALs (autolysosomes; mCherry-only punctae) were quantified in the intestine (**E**), body-wall muscle (**F**), pharynx (**G**), and hypodermal seam cells (**H**). Data are the mean ± SEM of 15 animals combined from two experiments \*\*\*p\<0.0001, \*\*p\<0.001, \*p\<0.01 by one-way ANOVA.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.010](10.7554/eLife.18459.010)10.7554/eLife.18459.011Figure 3---figure supplement 2.Hypothetical outcomes of autophagosome and autolysosome pool sizes following Bafilomycin A treatment.(**A**) Schematic representation of the possible outcomes of Bafilomycin A (BafA) treatment on autophagosomes (AP) and autolysosome (AL) pool sizes. An increase in autophagic vesicles could represent an induction or block in autophagic activity. If a change in either the AP or AL pool size is observed following BafA treatment, this is consistent with active autophagy, whereas no change in pool sizes following BafA indicates a block in autophagy. Possible changes in autophagic vesicles are indicated following (i) complete or (ii) partial inhibition of lysosomal acidification. (**B**) Diagram illustrating the relationship between changes in fluorescence signal of autophagic vesicles, corresponding pH, and lysosomal hydrolase activity, in response to efficacy of BafA (**i and ii**).**DOI:** [http://dx.doi.org/10.7554/eLife.18459.011](10.7554/eLife.18459.011)10.7554/eLife.18459.012Figure 3---figure supplement 3.Quantification of GFP::LGG-1 punctae during aging of animals expressing *gfp::lgg-1*.(**A--D**) Quantification of autophagosomes (AP; GFP punctae) in the intestine (**A**), body-wall muscle (**B**), pharynx (**C**), and nerve-ring neurons (**D**) at Days 1, 3, 5, 7, or 10 of adulthood in wild type (WT; dotted black same as [Figure 1F--I](#fig1){ref-type="fig"}), *daf-2(e1370)* (green), and *glp-1(e2141)* (blue). Data are the mean ± SEM of ≥20 animals combined from three independent experiments per time point. \*\*\*/\#\#\#p \< 0.0001, \*\*/\#\#p \< 0.001, and \*/\#p \< 0.01. \*\*\* for WT control vs *glp-1/daf-2* on each day; \#\#\# for WT/*glp-1*/*daf-2* control at Days 1, 3, 5, 7, or 10 vs. WT/*glp-1*/*daf-2* control at Day 1 by Poisson regression. (**E--H'**) Quantification of APs in WT (black line) and *daf-2(e1370)* animals (**E--H**, green) and WT and *glp-1(e2141)* animals (**E'--H'**, blue) injected with DMSO (control, black/dark green/dark blue) or Bafilomycin A (BafA, gray/light green/light blue) at Day 1 or Day 7 of adulthood. Tissues examined were the intestine (**E,E'**), body-wall muscle (**F,F'**), pharynx (**G,G'**), and nerve-ring neurons (**H,H'**). Data for WT animals are the same in (**E--H**) and (**E'--H'**). Data are the mean ± SEM of ≥25 animals combined from at least three experiments. Day 7 was omitted for neurons due to a counting issue of this time point. $^{\land}$, WT control vs. *daf-2* or *glp-1* control at Days 1 and 7; \*, *daf-2* or *glp-1* control vs. *daf-2* or *glp-1* + BafA at Days 1 and 7, ^\#^, *daf-2* or *glp-1* control at Day 7 vs. *daf-2* or *glp-1* control at Day 1. \*\*\*/$^{\land \land \land}$/^\#\#\#^p \< 0.0001, \*\*/$^{\land \land}$/^\#\#^p \< 0.001, \*/$^{\land}$/^\#^p \< 0.01 by Poisson regression.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.012](10.7554/eLife.18459.012)

We further validated the mCherry::GFP::LGG-1 reporter by investigating the effects of genetic (RNAi) or pharmacological inhibition of autophagy on AP and AL numbers. RNAi-mediated inhibition was achieved by feeding *mCherry::gfp::lgg-1* transgenic animals with bacteria expressing dsRNA for *rab-7*, a small GTPase required for AP--lysosome fusion ([Figure 2J](#fig2){ref-type="fig"} and \[[@bib41]\]). WT *mcherry::gfp::lgg-1* transgenic animals subjected to *rab-7* RNAi from hatching (whole-life RNAi) contained increased numbers of APs and reduced ALs in their intestines, as would be expected when autophagy is active and AP--lysosome fusion is inhibited ([Figure 2K](#fig2){ref-type="fig"}). We also pharmacologically inhibited autophagy by injecting WT *mcherry::gfp::lgg-1* transgenic animals with Bafilomycin A (BafA), which blocks vacuolar type H^+^-ATPases thus inhibiting lysosomal acidification ([Figure 2J](#fig2){ref-type="fig"} and \[[@bib31]\]). We confirmed this by showing that BafA abrogates LysoTracker staining in the intestine of Day 1 animals ([Figure 2---figure supplement 4A--B](#fig2s4){ref-type="fig"}). Consistent with a block in autophagy, we observed an increase in APs and a reduction in ALs in hypodermal seam cells of Day 1 transgenic WT animals injected with BafA compared with those injected with DMSO ([Figure 2L](#fig2){ref-type="fig"}). Lastly, we examined animals with a loss-of-function mutation in *cst-1*, the *C. elegans* ortholog of mammalian STK4; such mutants experience a block in autophagy ([@bib55]). While the number of APs in hypodermal seam cells of untreated mCherry::GFP::LGG-1-expressing *cst-1(tm1900) * mutants was higher than that of WT transgenic animals, as previously reported ([@bib55]), we observed no change in AP or AL pool sizes following BafA treatment of these animals ([Figure 2---figure supplement 4C](#fig2s4){ref-type="fig"}), consistent with the pre-existing genetic block in autophagy. Collectively, these results support the notion that the new mCherry::GFP::LGG-1 reporter identifies both AP and AL compartments and can be used to monitor changes in these compartments upon modulation of autophagy in adult *C. elegans*.

Aging of WT *C. elegans* is associated with an increase in the number of autophagic vesicles, which corresponds to a decrease in autophagic activity {#s2-4}
----------------------------------------------------------------------------------------------------------------------------------------------------

We next characterized tissue-specific changes in AP and AL pool sizes in the intestine, muscle, pharynx, and neurons of adult Days 1, 3, 5, 7, and 10 WT animals expressing *mCherry::gfp::lgg-1.* Similar to our analysis of WT animals expressing *gfp::lgg-1* ([Figure 1F--I](#fig1){ref-type="fig"}), we observed that WT animals expressing mCherry::GFP::LGG-1 displayed an increase in AP numbers in the intestine, muscle, and pharynx during late adulthood ([Figure 3A--C](#fig3){ref-type="fig"}), with the largest (\~15-fold) increase occurring in the muscle. Somewhat differently, the number of ALs in these tissues increased early in adulthood and then remained relatively constant until Day 10 ([Figure 3A--C](#fig3){ref-type="fig"}). In contrast, while neurons overall showed an increased number of APs when assessed with either the GFP::LGG-1 ([Figure 1I](#fig1){ref-type="fig"}), or the mCherry::GFP::LGG-1 reporter ([Figure 3D](#fig3){ref-type="fig"}), the number of ALs decreased with age ([Figure 3D](#fig3){ref-type="fig"}). Together, data with both fluorescent-tagged LGG-1 reporters indicate that the steady-state AP pool size increased with age in all the examined tissues of WT *C. elegans*, albeit with different trajectories, overall increasing confidence that APs are reliably monitored with the new tandem LGG-1 reporter. Likewise, the AL pool size appeared first to increase but then stagnate in the intestine, muscle, and pharynx of WT animals, whereas the number of ALs instead decreased over time in neurons.

An increase in APs and ALs could be due to an induction or a block in autophagy ([@bib30]). To distinguish between these possibilities, we injected BafA into WT transgenic animals during adulthood and quantified APs and ALs in each tissue two hours later, when steady-state conditions were reached ([Figure 3---figure supplement 1A--D](#fig3s1){ref-type="fig"}). Since BafA inhibits lysosomal acidification ([@bib31]), no change in AP and AL numbers following BafA treatment would be indicative of a block in autophagy, whereas BafA-induced changes in either AP or AL number, or both, would indicate active autophagy ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Specifically, complete inhibition of lysosomal acidification by BafA would reduce AL numbers (mCherry-only punctae) while increasing AP numbers (mCherry/GFP punctae) since the GFP signal would no longer be quenched ([Figure 3---figure supplement 2Ai,B](#fig3s2){ref-type="fig"}). However, BafA may also prevent the later step of cargo degradation by incompletely inhibiting acidification of the lysosome resulting in reduced efficiency of lysosomal enzymes, which could lead to a concomitant increase in AL numbers ([Figure 3---figure supplement 2Aii,B](#fig3s2){ref-type="fig"} and [@bib46]\]). We found that BafA treatment increased AP numbers in all tissues and at all ages of *mCherry::gfp::lgg-1* transgenic animals compared with controls, but the increases were generally dampened in older animals ([Figure 3A--D](#fig3){ref-type="fig"}). Similar observations were made in BafA-injected *gfp::lgg-1* transgenic animals ([Figure 3---figure supplement 3A--H](#fig3s3){ref-type="fig"}; analyzed at Day 1 and Day 7). This dampening of the response was not due to BafA being less effective at older age, since BafA equally quenched Lysotracker in the intestine of Day 1 and Day 10 animals ([Figure 2---figure supplement 4A--B](#fig2s4){ref-type="fig"}, and data not shown). Interestingly, AL numbers were increased by BafA in the intestine and pharynx at all ages and in the muscle of young animals ([Figure 3A--C](#fig3){ref-type="fig"}), whereas the effect on neurons varied with time ([Figure 3D](#fig3){ref-type="fig"}). Collectively, the observed changes in AP and AL pool sizes following BafA treatment suggest that autophagy is active in all tissues of WT *C. elegans* throughout life, similar to conclusions from a recent study ([@bib6]). However, the observation that older animals generally showed reduced responses to BafA is consistent with an overall reduction in autophagic activity in all tissues with age. Although we cannot at this point explain the variable age-related effects of BafA on AL pool size in neurons, we note that the BafA response in both AP and AL compartments at Day 10 was larger in neurons than in other tissues, suggesting that autophagic capacity in neurons may decline less with age. This possibility remains to be directly tested.

Taken together, our analysis is consistent with the GFP::LGG-1 and mCherry::GFP::LGG-1 reporters similarly monitoring APs, that the AP and AL pool sizes generally increase with age, and that autophagy is active in all tissues throughout adulthood in WT *C. elegans*, consistent with ([@bib6]). Importantly, however, the increased pool sizes appear to reflect an age-dependent decline in autophagic activity in all tissues.

Autophagic activity in hypodermal seam cells is increased in *daf-2* mutants, but can not be accurately assessed in *glp-1* mutants {#s2-5}
-----------------------------------------------------------------------------------------------------------------------------------

Mutations in the *daf-2* insulin/IGF-1 receptor or the *glp-1*/Notch receptor extend the lifespan of *C. elegans* ([@bib2]; [@bib28]), and reported evidence suggests that this is dependent on induction of autophagy. However, it is not known whether *daf-2* and *glp-1* mutants differentially regulate autophagy in a tissue- or age-specific manner to secure lifespan extension. To begin to investigate this, we assessed autophagy in a spatiotemporal manner in long-lived *daf-2(e1370)* and *glp-1(e2141)* mutants expressing the different fluorescently-tagged LGG-1 reporters.

We first analyzed hypodermal seam cells, the cell type that, thus far, has been the most frequently monitored using the GFP::LGG-1 reporter in *C. elegans* (reviewed in [@bib57]; [@bib18]). These cells display an increased number of GFP::LGG-1-positive punctae in both *daf-2(e1370)* and *glp-1(e2141)* larvae ([@bib43]; [@bib16]; [@bib35]). Consistently, we found that Day 1 *daf-2(e1370)* or *glp-1(e2141)* mutants expressing either GFP::LGG-1 or mCherry::GFP::LGG-1 displayed an increased AP pool size compared with WT, whereas AL numbers were similar between WT and the long-lived mutants ([Figure 4---figure supplement 1A--G](#fig4s1){ref-type="fig"}). However, expression of lipidation-deficient GFP::LGG-1(G116A) unexpectedly resulted in GFP-positive punctae in hypodermal seam cells of *glp-1(e2141)* mutants, whereas WT and *daf-2(e1370)* animals, as expected, showed diffuse GFP::LGG-1(G116A) localization ([Figure 4---figure supplement 1D--E](#fig4s1){ref-type="fig"}). Notably, both BafA ([Figure 4---figure supplement 1A--C](#fig4s1){ref-type="fig"}) and *rab-7* RNAi ([Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}) treatments caused an increase in APs and a reduction in ALs in *daf-2(e1370)* mutants expressing mCherry::GFP::LGG-1, but had no effect on AP or AL numbers in *glp-1(e2141)* mutants ([Figure 4---figure supplement 1A--C,G](#fig4s1){ref-type="fig"}; we note that BafA was equally effective in quenching Lysotracker in the intestine of WT, *daf-2,* and *glp-1* animals at Day 1 and Day 10 ([Figure 2---figure supplement 4A--B,D](#fig2s4){ref-type="fig"}, and data not shown). Taken together, these data are consistent with autophagy being induced in hypodermal seam cells of *daf-2* mutants, as proposed previously ([@bib43]). In contrast, hypodermal seam cells of *glp-1* animals may be different and cause LGG-1 to aggregate, as observed in autophagy-deficient mammalian cells expressing lipidation-deficient Atg8/LC3 ([@bib32]). Consistently, we observed punctate structures in *atg-3(bp412)* and *atg-18(gk378)* autophagy mutants expressing GFP::LGG-1(G116A) ([Figure 4---figure supplement 1H--I](#fig4s1){ref-type="fig"}). The exact nature of such lipidation-deficient GFP::LGG-1(G116A) punctate structures in *C. elegans* remains to be determined.

*daf-2* mutants generally display increased autophagic activity {#s2-6}
---------------------------------------------------------------

Since the GFP::LGG-1(G116A) reporter remained largely diffuse over time in the other major tissues we analyzed in *daf-2* and *glp-1* mutants, similar to WT animals ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), we next analyzed the GFP::LGG-1 and mCherry::GFP::LGG-1 reporters in the intestine, muscle, pharynx, and in neurons over time. Using both reporters, we observed the number of APs in the intestine and muscle were higher in *daf-2(e1370)* mutants than in WT animals at Day 1 and increased modestly with age until Day 10, at which time the AP levels in *daf-2(e1370)* mutants were lower than in WT animals ([Figure 4A--B](#fig4){ref-type="fig"}; [Figure 3---figure supplement 3A--B,E--F](#fig3s3){ref-type="fig"}). In contrast, while AL numbers were also elevated in the intestine and muscle of Day 1 *daf-2(e1370)* mutants with age ([Figure 4A--B](#fig4){ref-type="fig"}), AL numbers in the muscle increased in early adulthood and remained at relatively constant levels thereafter, whereas in the intestine, they continued to increase for longer. In both tissues, AL numbers in *daf-2(e1370)* mutants were higher than in WT animals at older ages ([Figure 4A--B](#fig4){ref-type="fig"}). Notably, BafA treatment generally increased the AP pool size in the intestine and muscle of *daf-2(e1370)* mutants expressing mCherry::GFP::LGG-1 ([Figure 4A--B](#fig4){ref-type="fig"}), or GFP::LGG-1 ([Figure 3---figure supplement 3E--F](#fig3s3){ref-type="fig"}). Of particular note, Day 10 animals showed the largest induction following BafA treatment in the intestine and muscle of *daf-2(e1370)* mutants, and AL pool size was also generally increased ([Figure 4A--B](#fig4){ref-type="fig"}). Collectively, these results suggest that autophagic activity may be elevated in the intestine and muscle of *daf-2* mutants compared with WT animals and may remain so throughout adulthood.10.7554/eLife.18459.013Figure 4.*daf-2* insulin/IGF-1 receptor mutants display increased autophagic activity in most tissues.(**A--D**) Quantification of autophagosomes (AP) and autolysosomes (AL) in adult Day 1, 3, 5, 7, and 10 *daf-2(e1370)* animals expressing *mCherry::gfp::lgg-1* and injected with DMSO (control, dark green lines) or Bafilomycin A (BafA, light green lines). Tissues examined were the intestine (**A**), body-wall muscle (**B**), pharynx (**C**), and nerve-ring neurons (**D**). The black dashed lines in (**A--C**) show data from wild-type (WT) control animals from [Figure 3](#fig3){ref-type="fig"} for comparison (animals were analyzed in parallel). The black dashed line in (**D**) shows data from WT animals incubated at 20°C for their entire lifespan. Data are the mean ± SEM of ≥25 animals combined from three independent experiments. ^∧^, WT control vs. *daf-2* control at Days 1, 3, 5, 7, and 10; \*, *daf-2* control vs. *daf-2* + BafA at Days 1, 3, 5, 7, and 10; ^\#^, *daf-2* control at Days 3, 5, 7, and 10 vs. *daf-2* control at Day 1. \*\*\*/^∧∧∧^/^\#\#\#^p\<0.0001, \*\*/^∧∧^/^\#\#^p\<0.001, \*/^∧^/^\#^p\<0.01 by Poisson regression. See also [Figure 3---figure supplement 1A--H](#fig3s1){ref-type="fig"} for quantification of APs in *gfp::lgg-1* transgenic animals.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.013](10.7554/eLife.18459.013)10.7554/eLife.18459.014Figure 4---figure supplement 1.Hypodermal seam cells in *daf-2* mutants display increased autophagy, whereas lipidation-independent punctate structures are present in these cells in *glp-1* mutants.(**A--C**) Quantification of autophagosomes (AP) (**A--B**) and autolysosomes (AL) (**C**) in hypodermal seam cells of adult Day 1 wild-type (WT), *daf-2(e1370)*, and *glp-1(e2141)* transgenic animals expressing *gfp::lgg-1* (**A**) or *mCherry::gfp::lgg-1* (**B--C**) and injected with DMSO (control) or Bafilomycin A (BafA). Data are the mean ± SEM of ≥25 animals combined from at least three independent experiments. \*\*\*p\<0.0001, \*p\<0.051 by one-way ANOVA. (**D--E**) Quantification of GFP-positive punctae in hypodermal seam cells of adult Day 1 WT and *daf-2(e1370)* animals raised at 20°C (**D**), and WT and *glp-1(e2141)* animals raised at 25°C (**E**) expressing WT *gfp::lgg-1* (LGG-1) or mutant *gfp::lgg-1* (LGG-1(G116A)). Data are the mean ± SEM from three independent experiments, each with ≥10 animals (one representative experiment shown). \*\*\*\*p\<0.0001 by one-way ANOVA. (**F--G**) Quantification of APs and ALs in the hypodermal seam cells of Day 1 WT and *daf-2(e1370* mutants expressing *mCherry::gfp::lgg-1* raised at 20°C (**F**) or Day 1 WT and *glp-1(e2141)* mutants expressing *mCherry::gfp::lgg-1* raised at 25°C (**G**) and fed from hatching with bacteria expressing empty vector (control) or dsRNA encoding *rab-7*. Data are the mean ± SEM of ≥40 animals combined from three experiments. \*\*\*\*p\<0.0001 and \*\*p\<0.005 by one-way ANOVA. (**H--I**) Quantification of GFP-positive punctae in hypodermal seam cells of adult Day 1 WT, *atg-3(bp412)* (**H**) and *atg-18(gk378)* (**I**) animals expressing WT *gfp::lgg-1* (LGG-1) or mutant *gfp::lgg-1* (LGG-1(G116A)). Animals were raised at 20°C. Data are the mean ± SEM combined from three independent experiments for *atg-3* with ≥22 animals combined from two independent experiments for *atg-18* with ≥16 animals. \*\*\*\*p\<0.0001, \*\*\*p\<0.001, \*\*p\<0.01, and \*p\<0.05 by one-way ANOVA.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.014](10.7554/eLife.18459.014)

In the pharynx, the AP pool size was similar in *daf-2(e1370)* and WT animals at most time points, whereas the AL pool size was initially larger in *daf-2(e1370)* mutants; however, in older *daf-2(e1370)* mutants, both AP and AL numbers were similar or lower than WT animals ([Figure 4C](#fig4){ref-type="fig"}, [Figure 3---figure supplement 3C,G](#fig3s3){ref-type="fig"}). Interestingly, BafA treatment did not cause any significant changes in AP numbers in the pharynx of *daf-2(e1370)* mutants, except at Day 10 of adulthood ([Figure 4C](#fig4){ref-type="fig"}, [Figure 3---figure supplement 3C,G](#fig3s3){ref-type="fig"}), whereas AL numbers were changed from Day 5 to Day 10 ([Figure 4C](#fig4){ref-type="fig"}). Collectively, these data indicate the interesting possibility that autophagy in the pharynx of *daf-2* mutants may be blocked prior to Day 5 of adulthood. Moreover, while enumeration of APs alone would suggest a continuous block in autophagy in the pharynx of *daf-2* mutants, the AL flux data is consistent with possible reactivation of autophagic activity that exceeds that of WT in late life. Additional experiments are needed to evaluate this possibility and to conclusively interpret the AL flux data, especially at older age.

The effect of age on the GFP::LGG-1 and mCherry::GFP::LGG-1 reporters in neurons was quite different to that in other tissues in *daf-2* mutants, but similar to that observed in WT animals. APs and ALs were more and less abundant, respectively, in *daf-2(e1370)* animals than in WT animals in early adulthood, but both strains displayed an overall decrease in APs and an increase in ALs as they aged ([Figure 4D](#fig4){ref-type="fig"}, [Figure 3---figure supplement 3D,H](#fig3s3){ref-type="fig"}). BafA treatment altered both AP and AL numbers throughout early adulthood in *daf-2(e1370)* animals ([Figure 4D](#fig4){ref-type="fig"}, [Figure 3---figure supplement 3H](#fig3s3){ref-type="fig"}), while at Day 10, BafA altered APs but not ALs ([Figure 4D](#fig4){ref-type="fig"}). Collectively, these data are consistent with autophagic activity in the neurons of *daf-2* mutants possibly being higher than in WT animals in early adulthood, whereas both strains display an age-related impairment of autophagic activity over time.

Overall, these data indicate that autophagic activity in the intestine, muscle, and neurons may be higher in *daf-2* mutants than in WT animals, at least in early adulthood. Notably, activity in the pharynx may possibly be blocked in younger *daf-2* mutants. This observation constitutes the first report of a potential block in autophagy in a long-lived animal, and needs to be investigated in more detail.

*glp-1* animals display a different autophagic activity profile than *daf-2* mutants {#s2-7}
------------------------------------------------------------------------------------

We performed a similar spatiotemporal analysis of the autophagy reporters in the major tissues of long-lived, germline-less *glp-1* mutants. We previously reported that GFP::LGG-1 punctae are more abundant in the intestine of *glp-1* mutants than of WT animals at Day 1 of adulthood ([@bib35]). Consistent with this, we observed elevated numbers of APs in the intestine of *glp-1(e2141)* animals compared with WT animals expressing either GFP::LGG-1 or mCherry::GFP::LGG-1 throughout adulthood except at old age ([Figure 5A](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3A,E'](#fig3s3){ref-type="fig"}). In contrast, the intestinal AL pool size was lower in *glp-1(e2141)* mutants than in WT animals at Day 1 of adulthood and fluctuated thereafter ([Figure 5A](#fig5){ref-type="fig"}). BafA treatment had variable effects on AP numbers but increased AL numbers in the intestine of both young and old animals ([Figure 5A](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3E'](#fig3s3){ref-type="fig"}). These results are consistent with autophagy being active in the intestine of *glp-1* animals throughout life, although this dataset is insufficient to make a direct comparison of the relative autophagic activity in *glp-1* mutants and WT animals.

In muscle, AP numbers were higher in *glp-1(e2141)* mutants than in WT animals in early adulthood but they increased similarly in both strains thereafter ([Figure 5B](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3B,F\'](#fig3s3){ref-type="fig"}). In contrast, AL numbers were generally lower in *glp-1(e2141)* mutants than in WT animals and remained relatively constant over time ([Figure 5B](#fig5){ref-type="fig"}). In this tissue, the BafA treatment, for unknown reasons, had variable effects on the two different reporter strains. Whereas *glp-1(e2141)* animals expressing GFP::LGG-1 showed induction of APs at both Day 1 and Day 7 ([Figure 3---figure supplement 3F'](#fig3s3){ref-type="fig"}), BafA had no significant effect on APs at any time point in *glp-1(e2141)* mutants expressing mCherry::GFP::LGG-1 ([Figure 5B](#fig5){ref-type="fig"}). ALs were similarly unaffected by BafA treatment in Days 1--5 *glp-1(e2141)* animals, yet altered in Day 7 and Day 10 *glp-1(e2141)* animals ([Figure 5B](#fig5){ref-type="fig"}). Thus, while additional experiments are needed to conclusively evaluate autophagy activity in the muscle of younger *glp-1* mutants, our observations indicate that autophagy may be active in this tissue of older *glp-1* mutants.

In the pharynx, *glp-1(e2141)* and WT animal's AP numbers were generally similar throughout adulthood ([Figure 5C](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3C,G'](#fig3s3){ref-type="fig"}), whereas the number of ALs increased somewhat with age but was consistently lower than in WT animals after Day 1 ([Figure 5C](#fig5){ref-type="fig"}). AP numbers in *glp-1(e2141)* mutants were generally unaffected by BafA treatment, whereas AL counts were altered in animals irrespective of age ([Figure 5C](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3C,G\'](#fig3s3){ref-type="fig"}). Thus, while the AL compartment needs to be fully investigated in older animals, it is possible that autophagy may remain active in the pharynx of *glp-1* mutants throughout life. However, similar to the intestine, it is not possible to evaluate the relative autophagic activity in *glp-1* mutants to WT animals based on this dataset.

In neurons, APs were more abundant in *glp-1(e2141)* mutants than in WT animals at Day 1, but were similar in older animals ([Figure 5D](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3D,H\'](#fig3s3){ref-type="fig"}). ALs were less abundant in the neurons of young Day 1 and Day 3 *glp-1(e2141)* mutants compared with WT animals, but ALs gradually decreased with age in WT animals while they remained relatively constant in *glp-1(e2141) *mutants ([Figure 5D](#fig5){ref-type="fig"}). Of note, BafA treatment of young *glp-1(e2141)* animals expressing either of the two LGG-1 reporters altered both AP and AL pool sizes ([Figure 5D](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3H'](#fig3s3){ref-type="fig"}), caused no significant effect on AP or AL number on Day 7 ([Figure 5D](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3H'](#fig3s3){ref-type="fig"}), but resulted in a significant increase in AP and ALs at Day 10 ([Figure 5D](#fig5){ref-type="fig"}). Taken together, these data indicate that autophagic activity may be increased in the neurons of young *glp-1* animals compared to age-matched WT animals, whereas the autophagic activity may become more comparable to that in WT animals by mid-life.10.7554/eLife.18459.015Figure 5.Germline-less *glp-1* mutants display a different autophagic activity profile than *daf-2* mutants.(**A--D**) Quantification of autophagosomes (AP) and autolysosomes (AL) in adult Days 1, 3, 5, 7, and 10 *glp-1(e2141)* animals expressing *mCherry::gfp::lgg-1* and injected with DMSO (control, dark blue lines) or Bafliomycin A (BafA, light blue lines). Tissues examined were the intestine (**A**), body-wall muscle (**B**), pharynx (**C**), and nerve-ring neurons (**D**). The black dashed lines in (**A--D**) show data from wild-type (WT) control animals from [Figure 3](#fig3){ref-type="fig"} for comparison (animals were analyzed in parallel). Data are the mean ± SEM of ≥25 animals combined from three independent experiments. ^∧^, WT + control vs. *glp-1* control at Days 1, 3, 5, 7, and 10; \*, *glp-1* control vs. *glp-1* + BafA at Days 1, 3, 5, 7, and 10, ^\#^, *glp-1* control at Days 3, 5, 7, and 10 vs. *glp-1* control at Day 1. \*\*\*/^∧∧∧^/^\#\#\#^p\<0.0001, \*\*/^∧∧^/^\#\#^p\<0.001, \*/^∧^/^\#^p\<0.01 by Poisson regression analysis.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.015](10.7554/eLife.18459.015)

Collectively, these data suggest that autophagy remains active in the intestine, pharynx, and possibly also muscle of *glp-1* mutants throughout adulthood. In neurons, autophagy appeared to be increased in young *glp-1* animals compared to WT animals and remains active and potentially comparable to WT by mid-life. Overall, aging had different tissue-specific effects of autophagy in *glp-1* mutants versus *daf-2* mutants, highlighting the possibility, which needs to be further addressed by yet-to-be developed biochemical assays, that autophagy may be regulated differentially at the individual tissue level in long-lived mutants.

Autophagy gene expression in the intestine is required for lifespan extension of *glp-1* mutants but not of *daf-2* mutants {#s2-8}
---------------------------------------------------------------------------------------------------------------------------

The intestine is a critical tissue in both *daf-2* and *glp-1* mutants, since the downstream effector DAF-16, a FOXO transcription factor functions in this tissue to ensure lifespan extension ([@bib38]). Since our tissue analyses indicated that autophagy is active in the intestine of both mutants, we asked whether intestine-specific inhibition of autophagy prevents lifespan extension in *daf-2* and *glp-1* animals, as has been observed with whole-body inhibition of autophagy ([@bib19]; [@bib35]; [@bib43]; [@bib16]). To this end, we used *sid-1(qt9)* mutants, which carry a mutation in the dsRNA transporter *sid-1* rendering them systemically refractory to RNAi, but with reconstituted *sid-1* expression specifically in the intestine using the *vha-6* promoter ([@bib44]). This strain was crossed to *daf-2(e1370)* and *glp-1(e2141)* mutants and lifespan analyses were carried out. The lifespans of the RNAi-refractory strains *daf-2(e1370); sid-1(qt9)* and *glp-1(e2141); sid-1(qt9)* with or without intestinal-specific *sid-1* re-expression were similar to the lifespans of *daf-2(e1370)* and *glp-1(e2141)* single mutants, respectively ([Supplementary file 1A--B](#SD1-data){ref-type="supplementary-material"}). Moreover, the lifespan of *daf-2(e1370); sid-1(qt9)* and *glp-1(e2141); sid-1(qt9)* double mutants were not affected by *atg-18*/*Wipi *RNAi ([Supplementary file 1A--B](#SD1-data){ref-type="supplementary-material"}), whereas the double mutants expressing *vha-6p::sid-1* were RNAi competent in the intestine, but not in the other tissues examined ([Figure 6---figure supplement 1A--E](#fig6s1){ref-type="fig"}, and data not shown). Together, these results validate the use of these strains for tissue-specific lifespan analyses.

While whole-body and intestinal-specific RNAi of *daf-16/Foxo* potently shortened the lifespan of both *glp-1(e2141)* and *daf-2(e1370)* mutants ([Figure 6A--B](#fig6){ref-type="fig"}; [Supplementary file 1A-B](#SD1-data){ref-type="supplementary-material"}), consistent with *daf-16* functioning in the intestine to extend the lifespan of these long-lived animals ([@bib38]), we found striking differences in longevity of *glp-1* and *daf-2* animals subjected to intestinal *atg-18* RNAi. Specifically, we observed that intestinal-specific inhibition of autophagy by *atg-18/Wipi* RNAi was sufficient to significantly reduce the lifespan of *glp-1(e2141)* animals, as previously observed with whole-body *atg-18/Wipi* RNAi ([Figure 6C](#fig6){ref-type="fig"}, [Supplementary file 1A](#SD1-data){ref-type="supplementary-material"}, and [@bib35]). In contrast, knockdown of *atg-18/Wipi* or of *lgg-1/Atg8* in the intestine of *daf-2(e1370)* animals did not have a significant effect on lifespan in a total of six out of six experiments, whereas whole-body *atg-18*/*Wipi* and *lgg-1/Atg8* RNAi had significant lifespan-shortening effects ([Figure 6D](#fig6){ref-type="fig"}, [Supplementary file 1B](#SD1-data){ref-type="supplementary-material"}), similar to the effect of whole-body RNAi of other autophagy genes ([@bib43]; [@bib16]; [@bib19]). Notably, we confirmed that *atg-18*/*Wipi* RNAi reduced the expression of an *mCherry::atg-18* transgene to the same extent in the intestine of WT and in *daf-2(e1370)* mutants ([Figure 6---figure supplement 1F,G](#fig6s1){ref-type="fig"}), indicating that knockdown of *atg-18* by RNAi is not somehow compromised in the intestine of *daf-2* mutants. Collectively, these data therefore indicate that intestinal autophagy is required for the lifespan extension of *glp-1* mutants, but not *daf-2* mutants.10.7554/eLife.18459.016Figure 6.Autophagy genes expressed in intestinal cells are required for lifespan extension of *glp-1* mutants, but not of *daf-2* mutants.(**A,C**) Kaplan--Meier survival curves of *glp-1(e2141)* single mutants and *glp-1(e2141); sid-1(qt9)* double mutants expressing *sid-1* cDNA in the intestine (*vha-6* promoter). Animals were fed from Day 1 of adulthood with bacteria expressing empty vector (control), *daf-16/Foxo* dsRNA (**A**), or *atg-18/Wipi* dsRNA (**C**). Intestine-specific inhibition of *daf-16/Foxo* shortened the lifespan of *glp-1(e2141)* mutants in two out of two experiments ach with ≥100 animals. p\<0.0001 for whole body control RNAi vs. whole body *daf-16/Foxo* RNAi; p\<0.0001 for intestine-specific control RNAi vs. intestine-specific *daf-16* RNAi by log-rank test. Intestine-specific inhibition of *atg-18/Wipi* shortened the lifespan of *glp-1(e2141)* mutants in five out of seven experiments, each with ≥100 animals. p\<0.0001 for whole-body control RNAi vs. whole-body *atg-18/Wipi* RNAi; p=0.0008 for intestine-specific control RNAi vs. intestine-specific *atg-18/Wipi* RNAi by log-rank test. (**B,D**) Kaplan--Meier survival curves of *daf-2(e1370)* single mutants and *daf-2(e1370); sid-1(qt9)* double mutants expressing *sid-1* cDNA in the intestine (*vha-6* promoter). Animals were fed from Day 1 of adulthood with bacteria expressing empty vector (control), *daf-16/Foxo* dsRNA (**B**), or *atg-18/Wipi* dsRNA (**D**). Intestine-specific inhibition of *daf-16/Foxo* shortened the lifespan of *daf-2(e1370)* mutants in two out of two experiments, each with ≥100 animals. p\<0.0001 for whole body control RNAi vs. whole body *daf-16/Foxo* RNAi; p\<0.0001 for intestine-specific control RNAi vs. intestine-specific *daf-16* RNAi by log-rank test. Intestine-specific inhibition of *atg-18/Wipi* had no significant effect on the lifespan of *daf-2(e1370)* mutants in all of six experiments, each with ≥100 animals. p\<0.0001 for whole-body control RNAi vs. whole-body *atg-18/Wipi* RNAi; p=0.66 for intestine-specific control RNAi vs. intestine-specific *atg-18/Wipi* RNAi, by log-rank test. See [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for details on lifespan analyses and additional repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.016](10.7554/eLife.18459.016)10.7554/eLife.18459.017Figure 6---figure supplement 1.Characterization of intestinal RNAi strains.(**A**) Differential interference contrast (DIC) images of Day 3 adult wild-type (WT, (**N2**), *daf-2 (e1370)*, *daf-2(e1370); sid-1(qt9)*, *sid-1(qt9); vha-6p::sid-1cDNA*, *daf-2(e1370); sid-1(qt9); vha-6p::sid-1cDNA*, *glp-1(e2141)*, *glp-1(e2141); sid-1(qt9)*, and *glp-1(e2141); sid-1(qt9); vha-6p::sid-1cDNA* animals fed from hatching with bacteria containing empty vector (control) or *elt-2 *dsRNA (*elt-2i*). Similar results were obtained with animals subjected to *pept-1* RNAi, whereas no response was obtained following RNAi knockdown of the muscle-specific gene, *unc-112,* and hypodermis-specific genes *bli-3, bli-4*, and *lin-26* in *sid-1*, *daf-2; sid-1,* or *glp-1; sid-1* strains expressing *sid-1* in the intestine (data not shown). Scale bar = 400 µm. Data representative of at least two independent experiments. (**B**) Fluorescence images (GFP), strains express *vha-6p::sid-1::sl2::gfp* and DIC images (insets) of Day 3 adult animals fed from hatching with bacteria containing empty vector (control) or *gfp*-encoding dsRNA. Scale bar = 200 µm. Data representative of at least two independent experiments. (**C**) Schematic of *sid-1* gene with primers 1, 2, and 3 indicated by arrows. Black boxes and lines indicate exons and introns, respectively. (**D,E**) PCR analysis using primers 1 and 3 (**D**), or 1 and 2 (**E**) to detect *sid-1* transgene expression in (**a**) *glp-1(e2141); sid-1(qt9),* (**b**) *daf-2(e1370); sid-1(qt9),* (**c**) *glp-1(e2141); sid-1(qt9); myo-3p::sid-1,* (**d**) *daf-2(e1370); sid-1(qt9); myo-3p::sid-1,* (**e**) *glp-1(e2141); sid-1(qt9); vha-6p::sid-1,* (**f**) *daf-2(e1370); sid-1(qt9); vha-6p::sid-1,* (**g**) *sid-1(qt9); vha-6p::sid-1,* and (**h**) WT animals. Data are representative of at least two independent experiments. Units are number of base pairs. (**F**) Fluorescence images (mCherry) of Day 1 adult WT or *daf-2(e1370)* transgenic animals expressing *atg-18p::atg-18::mCherry* fed from hatching with bacteria containing empty vector (control) or *atg-18/Wipi* dsRNA. (**G**) Quantification of fluorescence intensity in the anterior intestine of Day 1 adult WT or *daf-2(e1370)* animals expressing *atg-18p::atg-18::mCherry* fed from hatching with bacteria containing empty vector (control) or *atg-18/Wipi-*encoding dsRNA. Data are the mean ± SEM and are representative of three independent experiments, each with ≥10 animals. \*\*\*\*p\<0.0001 by one-way ANOVA. Scale bar = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.017](10.7554/eLife.18459.017)

This was a surprising result, because our autophagy flux assays indicated that *daf-2* mutants displayed active autophagy in the intestine ([Figure 4A](#fig4){ref-type="fig"}, [Figure 3---figure supplement 3A,E](#fig3s3){ref-type="fig"}), similar to *glp-1* mutants ([Figure 5A](#fig5){ref-type="fig"}, [Figure 3---figure supplement 3A,E'](#fig3s3){ref-type="fig"}). Autophagy in other tissues may instead play a role in the longevity of *daf-2* mutants. In support of this, we found that muscle-specific knockdown of *atg-18*/*Wipi* decreased the lifespan of *daf-2(e1370); sid-1(qt9)* animals expressing *sid-1* from the *myo-3* promoter ([Supplementary file 1B](#SD1-data){ref-type="supplementary-material"}). Of note, we observed the same lifespan-shortening effect of muscle-specific *atg-18*/*Wipi* RNAi in *glp-1(e2141)* mutants; in this case, however, *glp-1(e2141); sid-1(qt9)* mutants with *sid-1* re-expression in muscle were unexpectedly shorter-lived than *glp-1(e2141); sid-1(qt9)* mutants ([Supplementary file 1A](#SD1-data){ref-type="supplementary-material"}). Since the reason for this remains unclear, we refrain from drawing conclusions from this observation. Taken together, our lifespan analyses suggest that intestinal autophagy is required for lifespan extension in *glp-1* mutants, whereas autophagy in the muscle, but not the intestine, may contribute to the longevity of *daf-2* mutants.

Discussion {#s3}
==========

Changes in autophagy have been linked to aging in many species, but it is not yet clear how autophagy is modulated spatially and temporally during an animal's lifespan. Our analysis of *C. elegans* using multiple Atg8 reporters and autophagy flux assays is the first effort to comprehensively estimate autophagic activity in a living animal during aging. We found that (i) aging of wild-type (WT) animals is accompanied by increased numbers of autophagic vesicles in all tissues examined that likely reflects a reduction in autophagy activity; (ii) long-lived *daf-2* insulin/IGF-1 mutants and germline-less *glp-1* mutants differentially regulate autophagy spatially and temporally compared to WT animals, and (iii) *glp-1* mutants, but not *daf-2* mutants, require autophagy genes in the intestine for lifespan extension, further emphasizing important differences in autophagy regulation in individual tissues between these conserved longevity paradigms.

For this study, we used previously published GFP::LGG-1 ([@bib13]; [@bib26]; [@bib43]) and new mCherry::GFP::LGG-1 reporters (which were expressed from endogenous or neuronal promoters) to quantify autophagic events in four major somatic tissues, that is, intestine, muscle, pharynx, and neurons during *C. elegans* adulthood. As an important control to help verify that GFP::LGG-1-positive punctae observed in WT, *daf-2,* and *glp-1* animals likely represented APs and not unspecific aggregates, we also used a lipidation-deficient GFP::LGG-1(G116A) reporter expressed from the endogenous promoter ([@bib41]). Similar point-mutated Atg8 proteins are assumed unable to attach to the autophagosomal membrane since they cannot be post-translationally modified to bind phosphatidylethanolamine ([@bib24]). Consistent with this, GFP::LGG-1(G116A) appeared diffusely localized in essentially all the settings we investigated here, that is, in the intestine, muscle, and pharynx, with the notable exception of hypodermal seam cells in *glp-1* mutants in which GFP::LGG-1(G116A) expression led to punctae formation, similar to *glp-1* mutants expressing GFP::LGG-1 ([@bib35]). GFP::LGG-1 punctae in hypodermal seam cells of *glp-1* mutants may therefore have been incorrectly interpreted as APs. While GFP::LGG-1(G116A) punctate structures in *C. elegans* remains to be investigated in detail, they may be similar in nature to the intracellular protein aggregates or inclusion bodies observed in mammalian Atg5 knockout cells expressing GFP-tagged Atg8/LC3 ([@bib32]). Since Atg8 proteins are capable of oligomerization ([@bib47]; [@bib4]), GFP::LGG-1(G116A) punctate structures may alternatively still represent APs with mutant LGG-1(G116A) protein. However, methods to concretely determine whether GFP::LGG-1(G116A) punctae represent aggregates or APs (with WT and mutant LGG-1 protein) are not currently available in *C. elegans*. Collectively, these observations emphasize the use of analyzing a LGG-1(G116A) reporter in any given condition in which a fluorescent LGG-1 reporter is utilized to help assess autophagic vesicles, while the data from these reporters should be interpreted with caution. To this end, we note that a comprehensive analysis of such a reporter in neurons needs to be carried out since the GFP::LGG-1(G116A) reporter we used here limited us to only evaluate hypodermal seam cells, intestine, muscle, and pharynx in detail.

We used the GFP::LGG-1 and mCherry::GFP::LGG-1 reporters in combination with Bafilomycin (BafA) flux assays to quantify AP and AL numbers and estimate autophagic activity. These reporters equivalently monitored changes in the AP compartment in all tissues and at all ages, collectively increasing confidence that the AP compartment was accurately visualized with these reporters. Moreover, the mCherry::GFP::LGG-1 reporter rescued an embryonically lethal *lgg-1/Atg8* mutant, indicating that the full-length protein is functional. We sought to use this new reporter to monitor the AL compartment for the first time in adult *C. elegans* after validating it in multiple ways Specifically, we found that co-staining with Lysotracker highlighted the majority of red-only punctae in the intestine of young WT animals, as expected for acidic autolysosomes. In addition, we observed that inhibition of autophagy by either BafA, which inhibits lysosomal acidification, RNAi of *rab-7,* a gene required for AP-lysosome fusion, or genetic inhibition of autophagy by mutation of the Hippo kinase *cst-1*, all modulated AP and AL numbers in young WT and long-lived mutants as expected. While these observations collectively support the use of mCherry::GFP::LGG-1 to reliably monitor the AP and AL compartments, we were unable to account for \~15% red-only punctae in the intestine of Day 1 WT animals expressing mCherry::GFP::LGG-1. A similar low percentage of red-only punctae was observed in the intestine of Day 1 *daf-2* and *glp-1* mutants ([Figure 2---figure supplement 4D](#fig2s4){ref-type="fig"}). These punctae could represent aggregates, or, alternatively, inefficient Lysotracker staining (as noted in results), however, at present we cannot distinguish between these possibilities and this estimate does not significantly offset any of our conclusions. While this estimate is very low, and has, to our knowledge, not previously been estimated for a tandem-tagged Atg8 reporter in any model system including mammalian cell culture, we emphasize that additional experiments are needed to fully verify the AL compartment in other *C. elegans* tissues and at later time points. To this end, it will be important to evaluate a lipidation-deficient mCherry::GFP::LGG-1(G116A) mutant. Moreover, it would be of interest to estimate autophagic activity via the Atg8 paralog LGG-2 in *C. elegans* ([@bib1]).

Our BafA flux assays indicated that although autophagy is active in the intestine, muscle, pharynx, and neurons of aging WT *C. elegans,* autophagic activity appeared to decrease with age. These results are consistent with flux assays and proteolysis experiments in rat liver ([@bib9], [@bib11]), gene expression studies in *D. melanogaster* and rodents ([@bib8]; [@bib10]; [@bib27]; [@bib39]; [@bib52]; [@bib54]; [@bib56]), and lysosomal protease studies in *C. elegans* ([@bib51]). Our observations are also consistent with the findings of a recent study of tissue-specific autophagy in *C. elegans*, which showed that autophagy is active in all major somatic tissues during aging ([@bib6]). In that study, *C. elegans* expressing a lysosomal-cleavable dual-fluorescent LGG-1 protein showed an age-associated increase in mono-fluorescent LGG-1 protein levels, which the authors interpreted as an increase in autophagic activity ([@bib6]). However, the accumulation of this mono-fluorescent protein would also be consistent with an age-dependent decline in autophagic activity if degradation is inhibited, perhaps through reduced lysosomal pH or enzymatic activity, as has been observed in aging yeast ([@bib23]). How lysosomal pH and activity might change in individual *C. elegans* tissues during aging is an important question for the future and will be especially interesting to investigate in neurons, which appeared to behave differently to other major tissues with respect to autophagic activity. The apparent decline in autophagic activity observed here could have several explanations, including an age-associated failure to clear the autophagic machinery (as evidenced by the increases in AP and AL pool sizes) or to degrade otherwise detrimental cargo. Additional assays are required to confirm these interpretations, including biochemical approaches to directly address how autophagy might fail with age in the different tissues of *C. elegans*; such efforts may be facilitated by novel tissue-isolation methods ([@bib25]). It will also be interesting to investigate how an age-dependent decline of autophagy in specific tissues might contribute to loss of organ-specific functions during aging.

Our analysis suggested that autophagic activity might be increased in certain tissues of long-lived *daf-2* and *glp-1* mutants compared with WT animals, as we and others have previously proposed ([@bib35]; [@bib43]). However, our results indicate that these two longevity mutants differentially regulate autophagy in a tissue-specific manner during aging since *daf-2* and *glp-1* mutants showed distinct age-related changes in AP and AL pool sizes, as well as in autophagic flux. Of particular note, we found that autophagy appeared to be blocked in the pharynx of Day 1 adult *daf-2* animals. This is an interesting scenario as it would constitute the first example of a possible autophagy block in a long-lived animal; however, we caution that steady-state conditions for the BafA treatment could vary between genetic background, tissue, as well as age. Irrespectively, it remains to be determined how *daf-2* and *glp-1* mutants may differentially regulate autophagy, and to this point, it is interesting to note that although both mutants require the transcription factor HLH-30/TFEB for longevity ([@bib34]), *glp-1* mutants upregulate more predicted HLH-30 target genes with roles in autophagy than *daf-2* mutants ([@bib34]). While the endpoint of our analysis was on Day 10 of adulthood, it will also be of interest to estimate autophagic activity in physiologically old long-lived mutants, including in their late state of decrepitude likely caused by bacterial colonization ([@bib48]).

We observed that intestine-specific inhibition of autophagy genes significantly shortened the lifespan of *glp-1* animals, but not *daf-2* animals, suggesting that the apparent increase in intestinal autophagic activity in *daf-2* mutants may not be required for their long lifespan. Since systemic inhibition of autophagy reduces the lifespan of both mutants (reviewed in [@bib18], and this study), autophagy in other tissues, such as muscle, may be more important for longevity in *daf-2* mutants. These results further highlight important differences in autophagy regulation between *daf-2* and *glp-1* mutants and suggest that autophagy in different organs may have distinct biological roles; a possibility that is further emphasized by the observed differential requirement for autophagy in lifespan determination in the intestine of *daf-2* versus *glp-1* animals. To this end, it will be interesting to determine whether autophagy is regulated in a tissue-specific manner in other long-lived *C. elegans* mutants, or in other long-lived species.

In this study, we evaluated overall autophagic activity by quantifying steady-state levels of APs and ALs in combination with autophagic flux assays. However, autophagy is a multistep process and further insight can be gained into its regulation by taking into account that each step occurs at a distinct rate. Below, we reassess our dataset with this in mind. If we assume that autophagy can be represented by three steps: isolation membrane (IM) to AP, AP to AL, and degradation of ALs, the rates of each step under steady-state conditions can be defined as the concentration of IMs, APs, and ALs multiplied by the rate constants α, β, and γ, respectively ([Figure 2---figure supplement 3A--B](#fig2s3){ref-type="fig"} and \[[@bib40]\]). Changes in the steady-state levels of APs and ALs can therefore provide information about the relative contribution of the change in each step to the overall autophagic flux. For example, in WT *C. elegans* under steady-state conditions, ALs were consistently more abundant than APs in all tissues examined, as has been observed in some mammalian cell types ([@bib30]), and in *D. melanogaster* tissues ([@bib42]). Assuming α is constant, this observation suggests that β is greater than γ (i.e. the degradation step is slower than the AP to AL step), implying that turnover of ALs may be rate limiting in *C. elegans* ([Figure 2---figure supplement 3B--C](#fig2s3){ref-type="fig"}). We can similarly approximate how BafA treatment affects each step and rate constant since the ratio of \[AP\] in control-treated animals to \[AP\] in BafA-treated animals (and similarly for \[AL\]) is inversely correlated to the change in β (or γ). For example, an increase in both \[AP\] and \[AL\] following BafA treatment implies that BafA reduces both β and γ ([Figure 2---figure supplement 3B,D](#fig2s3){ref-type="fig"}). In fact, we observed that each tissue in WT, *daf-2*, and *glp-1* animals responded to BafA in a different manner according to the genetic background and age of the animal, suggesting that tissue-, age-, and genotype-specific differences may exist in the autophagy-rate constants. The above analysis also clearly indicates that, while quantification of autophagic vesicles at steady state provides valuable information about autophagic activity, it at times is not sufficient to accurately determine the relative difference in autophagic activity between WT, *daf-2,* and *glp-1* animals, or between the tissues examined. Moreover, a hypothetical modeling of our data shows that steady-state numbers of APs and ALs can be interpreted as increased, decreased, or unchanged autophagic flux when the rate constants differ ([Figure 2---figure supplement 3E](#fig2s3){ref-type="fig"}), again cautioning that steady-state measurements of AP or AL pool sizes may not reflect the overall autophagic flux. Therefore, additional methods that directly measure the rate of at least one step in autophagy or the overall rate of autophagic degradation will be crucial to accurately measure autophagic flux and fully understand its role in longevity.

In conclusion, our autophagic flux analysis using LGG-1/Atg8 reporters indicated an age-dependent decline in autophagy in several major tissues of *C. elegans,* and that the reduction occurs at a step after AP formation. In contrast, long-lived animals show differential regulation of autophagy in distinct tissues. Further experiments are needed to confirm these observations by directly measuring autophagic activity. Understanding the tissue- and age-specific regulation of autophagy in *C. elegans* is likely to shed light on the role of autophagy in aging and age-related diseases in mammals, including humans.

Materials and methods {#s4}
=====================

*C. elegans* and bacterial strains {#s4-1}
----------------------------------

*C. elegans* strains were maintained and cultured under standard conditions at 20°C on the standard *E. coli* strain OP50 (see [Supplementary file 2](#SD2-data){ref-type="supplementary-material"} for strain list). HT115 was used as the food source for feeding RNAi experiments ([@bib5]). For experiments with the temperature-sensitive *glp-1(e2141)* mutant, both *glp-1(e2141)* and wild-type (WT) N2 animals were allowed to hatch at 20°C for 24 hr and then moved to 25°C until Day 1 of adulthood. At Day 1 of adulthood, all strains were placed at 20°C for the rest of the analysis. All *daf-2(e1370)* strains were maintained at 20°C for their entire lifespan. WT animals were raised at 25°C and placed at 20°C at Day 1 of adulthood, with the exception of WT animals expressing the mCherry::GFP::LGG-1 transgene specifically in neurons ([Figure 4D](#fig4){ref-type="fig"}) or otherwise noted, which were maintained at 20°C for their entire lifespan. No significant difference was observed in AP and AL pool sizes in Day 1 or Day 3 adult animals raised at 20°C or 25°C ([Figure 3---figure supplement 1E--H](#fig3s1){ref-type="fig"}).

RNA interference (RNAi) {#s4-2}
-----------------------

HT115 RNAi clones used were *bli-3, bli-4, elt-2, lin-26, lgg-1, pept-1, rab-7*, and *unc-112* (all Ahringer library), *atg-18* (Vidal library), as well as *daf-16* and *gfp* (kind gifts from Dr. Andrew Dillin). All RNAi bacterial clones were verified by sequencing. The empty vector (L4440) for controls was provided by Dr. Andrew Fire. RNAi experiments were carried out as previously described ([@bib13]). Briefly, HT115 bacteria were grown in liquid LB medium containing 0.1 mg/ml carbenicillin (BioPioneer, San Diego, CA), 80 µl bacteria spotted onto 6 cm NGM plates supplemented with carbenicillin and grown for 1--2 days at room temperature, and 80 µl 0.1M IPTG (Promega, Sunnyvale, CA) added to bacterial lawn to induce dsRNA expression. Eggs (whole-life RNAi) or adults (adult-only RNAi) were transferred to plates. RNAi of *bli-3, bli-4, elt-2, gfp, lin-26, pept-1, rab-7*, and *unc-112* was performed from hatching, and *lgg-1, daf-16,* and *atg-18* RNAi used in lifespan analyses was performed from Day 1 of adulthood.

To confirm efficacy of *atg-18* RNAi in *daf-2* animals, transgenic WT or *daf-2(e1370)* animals expressing *atg-18p::atg-18::mCherry* from and extrachromosomal array were fed bacteria expressing *atg-18* dsRNA from hatching and imaged using a Leica fluorescence dissecting microscope at 23x magnification. Images were acquired using a Leica DFC310 FX camera with 4 second exposure. Fluorescence intensity in the anterior intestine was determined using Image J.

Construction of transgenic strains {#s4-3}
----------------------------------

To construct the *lgg-1p::mcherry::gfp::lgg-1* vector, *mCherry* was amplified by PCR from a Clontech pmCherry expression vector and the PCR fragment was inserted into TOPO TA vector. *mCherry* was verified by sequencing and then removed using Kpn1 and inserted into an *lgg-1p::gfp:lgg-1* vector ([@bib43]) upstream of *gfp*. The final product *lgg-1p::mcherry::gfp::lgg-1* (pMH878) was verified by sequencing.

An expression plasmid for neuronal-specific *rgef-1p::mCherry::gfp::lgg-1* was generated by Gateway cloning technology lambda (Thermo Fisher Scientific, Waltham, MA) ([@bib20]) using pDONR P4-P1R-*rgef-1p* (\~1.6 kb, amplified from a vector provided by the Dillin lab), pDONR221-*mCherry::gfp::lgg-1* open-reading frame (amplified from pMH878), and pDONR-P2RP3-*unc-54 3′UTR* (amplified from pGH8 \[[@bib12]\]). The final product *rgef-1p::mcherry::gfp::lgg-1* (pMH1130) was verified by sequencing. An expression plasmid for *atg-18p::atg-18::mCherry* was similarly made using pDONR P4-P1R-*atg-18p* (540 bp, amplified from genomic DNA) and pDONR221-*atg-18* open-reading frame (amplified from genomic DNA). The final product *atg-18p::atg-18::mCherry* (pMH791) was verified by sequencing.

Plasmid DNA was prepared using a Mini or Midi Prep kit (Invitrogen, Waltham, MA or Qiagen, Hilden, Germany). Transgenic animals expressing an extrachromosomal array were created by gonadal microinjection of pMH878/*lgg-1p::mCherry::gfp::lgg-1,* pMH1130/*rgef-1p::mCherry::gfp::lgg-1,* or pMH791/*atg-18p::atg-18::mCherry* plus pRF4/*rol-*6 co-injection marker into N2-Hansen animals. A list of strains made in this study is provided in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. Integration of *lgg-1p::mCherry::gfp::lgg-1* was subsequently performed by γ-irradiation followed by outcrossing four times to N2-Hansen WT animals.

To show that *lgg-1p::mCherry::gfp::lgg-1* was functional and could rescue the *lgg-1* mutant embryonic lethality, MAH215/*lgg-1p::mCherry::gfp::lgg-1* was crossed to FX3489/*lgg-1(tm3489) II/+*, and the mCherry/GFP-positive F2 progeny were assayed for the homozygous *lgg-1* mutation by PCR. Mutated *lgg-1* is \~800 bp and WT *lgg-1* is \~1000 bp. Viable and fertile animals that were positive for mCherry/GFP were identified with mutant *lgg-1*. Primer information is available in [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}.

Quantification of autophagic vesicles {#s4-4}
-------------------------------------

*C. elegans* were mounted live on a 2% agarose pad in M9 medium containing 0.1% NaN~3~ and imaged using an LSM Zeiss 710 scanning confocal microscope, Z-stack images were acquired at 0.6 µm slice intervals at 63x. GFP excitation/emission was set to 493/517 nm to eliminate background autofluorescence. GFP::LGG-1 (GFP) or mCherry::GFP::LGG-1 (mCherry/GFP or mCherry only)-positive punctae were counted in the hypodermal seam cells, intestine, body-wall muscle, pharynx, and nerve-ring neurons in one 0.6 µm slice. The Z-position was selected where the nucleus could be clearly seen (for hypodermal seam cells and intestine), where striation could be seen (body-wall muscle), and where the lumen of the pharyngeal bulbs was in focus (for the pharynx and nerve-ring neurons). Punctae were quantified from images as follows: for body-wall muscle, punctae in one 1000 µm^2^ area per 0.6 µm slice per animal, for the nerve-ring neurons total punctae between the pharyngeal bulbs in one 0.6 µm slice per animal, for the pharynx the number of punctae in the posterior pharyngeal bulb, and for the intestine and hypodermal seam cells, the number of punctae per cell per 0.6 µm slice. The number of mCherry-only punctae was calculated as (the total number of mCherry-positive punctae -- the number of GFP-positive punctae). Statistical analysis of punctae was performed using Poisson regression calculated with the [@bib50]. The intensity of red fluorescence compared to green is stronger and in order to see mCherry-positive punctae clearly, the gain of the red channel was purposely set lower. If the intensity of red fluorescence was increased (which would overexpose the red punctae), cytoplasmic mCherry::GFP::LGG-1 appeared yellow (data not shown). For GFP::LGG-1(G116A) experiments, punctae in hypodermal seam cells were counted using a Zeiss Imager Z1, while at the microscope. The total number of punctae was counted in all visible hypodermal seam cells, whereas punctae quantification in the intestine, body-wall muscle, and pharynx was done as specified above. Imaging was performed using Zeiss Imager Z1 including apotome.2 at 100x magnification with a Hamamastsu orca flash 4LT camera and Zen 2.3 software. The average and SEM were calculated and data were analyzed using one-way analysis of variance (ANOVA) or two-way ANOVA as applicable (GraphPad Prism, La Jolla, CA).

Bafilomycin A and LysoTracker treatment {#s4-5}
---------------------------------------

Bafilomycin A (BafA; BioViotica, Dransfeld, Germany) was injected into the body cavity of *C. elegans* as previously described ([@bib55]). Briefly, 50 µM of BafA in 0.2% DMSO (25 mM stock in DMSO) or 0.2% DMSO (control) was co-injected with 2.5 ug/ml Texas Red Dextran or Cascade Blue Dextran, 3,000 Daltons (re-suspended in water at a stock concentration of 25 ug/ml; Thermo Fisher Scientific, Walltham, MA) into the anterior body cavity, intestine, or intestinal lumen, and the animals were allowed to recover for two hours before they were imaged by confocal microscopy. Injection of BafA could result in variability of LGG-1 punctae counts; however, injection of the 3,000 Dalton Texas Red Dextran alone (i.e. significantly larger than BafA) into \~100 worms showed highly reproducible Texas Red signal in the head region where LGG-1 punctae were quantified (data not shown), and the standard error of the mean was similar in DMSO- and in BafA-treated animals in all experiments performed (as well as in published work, see \[[@bib55]\]). Thus, notable variability in number of punctae is likely due to variability per animal rather than variable injection of BafA.

*C. elegans* were grown from egg to adulthood on *E. coli* OP50-seeded NGM plates containing 25 μM LysoTracker Deep Red (Thermo Fisher Scientific, Waltham, MA, mixed into plate media during prep) or an equivalent volume of DMSO (control) and subsequently imaged using confocal microscopy.

Lifespan analysis {#s4-6}
-----------------

Lifespan was measured at 20°C as previously described ([@bib17]). Briefly, synchronized animals were transferred onto *E. coli* OP50-seeded plates and were raised at 20°C for WT/*daf-*2 lifespans while animals for WT/*glp-1* lifespans were left at 20°C for 24 hr then moved to 25°C for 48 hr. At Day 1 of adulthood all animals were moved to 20°C for the rest of their lives. The animals were then transferred to plates seeded with HT115 RNAi clones (adult-only RNAi treatment) or bacteria contain empty vector (controls) and scored every 1--3 days, as previously described ([@bib17]). Animals were scored as dead if they failed to respond to gentle prodding with a platinum wire pick. Censoring occurred if animals desiccated on the edge of the plate, escaped, ruptured, or suffered from internal hatching. Kaplan--Meier survival curves were constructed and statistical analysis was performed using STATA software (StataCorp, College Station, TX). p-values were calculated using the log-rank (Mantel--Cox) method.

Analysis of the *sid-1* transgene {#s4-7}
---------------------------------

Intestine-specific *sid-1* transgene expression was assessed by PCR (see [Supplementary file 3](#SD3-data){ref-type="supplementary-material"} for primer list). All *daf-2* and *glp-1* strains carrying *sid-1* transgenes were tested and confirmed for RNAi efficiency using multiple tissue-specific RNAi clones for genes expressed in the intestine, body-wall muscle or hypodermis ([Figure 6---figure supplement 1A--B](#fig6s1){ref-type="fig"}, data not shown) as previously described for WT tissue-specific RNAi strains ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, and [@bib33], and data not shown). Briefly, strains carrying *sid-1* transgenes were subjected to whole-life tissue-specific RNAi and imaged at Day 3 of adulthood. Worms were imaged in M9 medium containing 0.1% NaN~3~ on a Leica fluorescence dissecting microscope at 8x magnification. Images were acquired using a Leica DFC310 FX camera with 2-second exposure.

Immunoblotting {#s4-8}
--------------

Total protein was extracted from 50 handpicked Day 1 adult animals grown on OP50 bacteria at 20°C. Animals were washed thoroughly in M9 buffer and centrifuged, and the pellets were lysed in 10 μl of 6x SDS sample buffer. The entire extract was separated by 4--20% SDS-PAGE (Thermo Fisher Scientific, Waltham, MA) and transferred to a PVDF membrane (Millipore, Hayward, CA). Immunoblotting was performed using primary anti-GFP (diluted 1:1000; Santa Cruz Biotechnology, Dallas, TX), anti-mCherry (diluted 1:500; Clontech, Mountain View, CA), and anti-LGG-1 (diluted 1:1000; sample kindly obtained from Abgent, San Diego, CA) antibodies and secondary horseradish peroxidase-conjugated goat anti-mouse (diluted 1:2000; Santa Cruz Biotechnology, Dallas, TX) or goat anti-rabbit (1:2000; Cell Signaling Technology, Danvers, MA) secondary antibodies. Immunoblots were developed using enhanced chemiluminescent reagent (Thermo Fisher Scientific, Waltham, MA).

Immunofluorescence in *C. elegans* intestines {#s4-9}
---------------------------------------------

Day 1 adult transgenic animals expressing *mcherry::gfp::lgg-1* were picked into a drop of M9 on a glass slide and dissected by pulling the head and tail apart with forceps, resulting in the intestine popping out of the animal. Dissected intestines were transferred to a 1.5-ml tube and fixed in 4% paraformaldehyde in 0.1% PBS-Tween20 for one hour at room temperature, and rinsed at least three times in 0.1% PBS-Tween20. Intestines were blocked in 5% FBS +0.1% PBS-Tween20 overnight at 4°C. Primary antibodies were mouse anti-GFP (diluted 1:100; Santa Cruz Biotechnology, Dallas, TX), mouse anti-mCherry (diluted 1:50; Clontech, Mountain View, CA), and rabbit anti-LGG-1 (diluted 1:100; sample kindly providd by Abgent, San Diego, CA); they were diluted in block and incubated overnight at 4°C. Secondary antibodies used were goat anti-mouse AlexaFluor 546 (1:500 Life Technologies, Carlsbad, CA) and goat anti-rabbit AlexaFluor 488 (1:500 Life Technologies, Carlsbad, CA) and incubated in block overnight at 4°C. Dissected intestines were flat mounted in glycerol directly onto glass slides and imaged using an LSM Zeiss 710 scanning confocal microscope. Secondary antibody-only treatment did not have any specific antibody staining in the intestine (data not shown). Fixation quenched mCherry/GFP fluorescence in the intestine, but not in the pharynx, body-wall muscle or hypodermis, as these tissues were not exposed as much as the intestine to the fixing solution and sometimes appeared to be fluorescent (both green and red) following secondary antibody-only treatment. N2/WT animals treated with secondary antibodies only did not show fluorescence staining in the body-wall muscle, pharynx, or hypodermis demonstrating that fluorescence in transgenic animals is due to the reporter that was not quenched during fixation (data not shown).
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###### (A--B) Lifespan analysis of *daf-2* and *glp-1* animals subjected to whole-body or tissue-specific RNAi of autophagy genes during adulthood.

Lifespan analysis of *glp-1(e2141)* and *glp-1(e2141); sid-1(qt9)* (**A**), and *daf-2(e1370)* and *daf-2(e1370); sid-1(qt9)* (**B**) animals carrying tissue-specific arrays to re-establish RNAi by expression of *sid-1* transgene from intestinal-specific (*vha-6*) or muscle-specific (*myo-3*) promoters. WT and *daf-2* animals were incubated at 20°C and fed from Day 1 of adulthood with bacteria containing empty vector (control) or expressing dsRNA encoding autophagy genes *atg-18/Wipi*,* lgg-1/Atg8* or *daf-16/Foxo. glp-1(e2141)* animals were raised at 25°C and moved to 20°C at Day 1 of adulthood for the rest of their lifespan. Individual experiments are numbered (Exp\#). We note that *lgg-1* RNAi did not significantly shorten the lifespan of *glp-1(e2141); sid-1(qt9); vha-6p::sid-1* transgenic animals, but this treatment had relatively weak effects in *glp-1(e2141)* single mutants analyzed in parallel experiments. Moreover, the *glp-1; sid-1; vha-6p::sid-1* strain was, for unexplainable reasons, short-lived in experiment number 5. Whole-body, muscle-specific, and intestinal-specific inhibition of autophagy genes generally had no effect or slightly decreased the lifespan of wild-type N2 animals (JTC and MH, unpublished results). Data show the average lifespan (avg. LS), the number of events (\# animals/Total; number of dead animals/total number of animals analyzed, the percentage lifespan extension (% change) of animals subjected to gene-specific vs control RNAi, and the p value for this comparison. p values were calculated using the Mantel--Cox log-rank test. \*data shown in [Figure 6](#fig6){ref-type="fig"}.

**DOI:** [http://dx.doi.org/10.7554/eLife.18459.018](10.7554/eLife.18459.018)

10.7554/eLife.18459.019

###### *C. elegans* strains used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.18459.019](10.7554/eLife.18459.019)

10.7554/eLife.18459.020

###### Primers used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.18459.020](10.7554/eLife.18459.020)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Spatiotemporal regulation of autophagy during *C. elegans* aging\" for consideration by *eLife*. Your article has been favorably evaluated by Sean Morrison (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, the authors investigated autophagic flux in multiple tissues during the aging process using the tandem-tagged Atg8/LGG-1 reporter. They found that autophagic activity declines with age in all major tissues. They also showed that long-lived *daf-2* and *glp-1* mutant animals exhibit unique age- and tissue-specific differences in autophagic activity. Compared with wild type animals, *daf-2* mutants display elevated autophagic activity, while *glp-1* mutants show reduced autophagic activity in the hypodermal seam cells. Using tissue-specific RNAi, the authors demonstrated that intestinal autophagy is essential for lifespan extension only in *glp-1* mutants. Overall, the work is interesting. The reviewers found that additional work is required to strengthen the manuscript to meet the standards for *eLife*.

Essential revisions:

1\) This study relies heavily on the tandem nCherry-gfp-lgg-1 reporter to monitor autophagic flux. It has been shown that overexpressed Atg8/LC3 reporters not only form aggregates but can also label non-autophagic structures (such as the Golgi) in yeast and mammalian cells. Further validation of the tandem reporter using Atg gene mutant backgrounds would be necessary in the different tissues.

A\) LGG-1/ATG8 must be lipidated in order for it to form punctate structures. The transgenic reporter could be crossed into various autophagy gene mutants that abolish LGG-1 lipidation, including *atg-4.1; atg-4.2, atg-16.1; atg-16.2, atg-3, atg7*, and then the formation of puncta can be examined. If mCherry-gfp-lgg-1 puncta are absent in those mutants, it indicates that the puncta represent autophagic structures. The expression of this tandem reporter could also be examined in mutants of the Atg1 kinase complex, in which LGG-1 displays a unique distribution pattern at embryonic stages.

B\) Endogenous LGG-1, detected by anti-LGG-1, could be used to demonstrate the change in autophagy activity in aged animals.

2\) The authors show that autophagy in hypodermal seam cells is induced in daf-2 mutants but blocked in germline-less *glp-1* mutants. However, the numbers of APs and ALs are pretty low in this tissue in wild type and mutant animals with or without Bafilomycin treatment. Other assays such as degradation of the well-characterized autophagy substrate SQST-1 in partial loss-of-function autophagy mutants need be performed to demonstrate the differential autophagy activity in *daf-2* and *glp-1* mutants.

3\) Bafilomycin treatment was used to block lysosome degradation in this study. However, Bafilomycin was administered by injection, which may result in variation among animals. Genetic mutants with impaired lysosomal function, including *cup-5* and *laat-1*, could be used to follow the number of APs and ALs in aged animals or long-lived mutants.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Spatiotemporal regulation of autophagy during *C. elegans* aging\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Sean Morrison (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

Other assays are needed to demonstrate that mCherry::GFP::LGG-1 puncta are autophagic structures but not protein aggregates. Anti-LGG-1 antibody could be used to detect endogenous LGG-1 (not in animals carrying the transgene) pattern in larvae. SQST-1 could also be stained to see whether it is colocalized with mCherry::GFP::LGG-1 puncta (three color staining).

*Reviewer \#1:*

The authors have addressed many of my concerns. But they need clarify/address the following remaining concerns:

1\) *atg-3(bp412)* is not a null allele. Genetic nulls for two conjugation systems are lethal. Thus, alternative explanation for the formation of LGG-1 puncta in *atg-3(bp412)* larvae need be discussed.

2\) The authors performed immunostaining against endogenous LGG-1 in animals carrying the mCherry::gfp::lgg-1 transgene. The antibody for sure will recognize MCHERRY::GFP::LGG-1 expressed from the transgene. Such experiments should be carried out in animals without carrying the transgene.

*Reviewer \#2:*

In their revised manuscript, the authors test the punctate distribution of their new mCherry::GFP::LGG-1 reporter in various Atg loss-of-function backgrounds to validate its use for the analysis of autophagic activity. As expected, they show that the number of mCherry-positive, GFP-negative dots (autolysosomes) decreases in these situations. However, surprisingly, the number of structures positive for both mCherry and GFP increases upon loss of Atg genes such as Atg3 that is required for LGG-1 lipidation and membrane association. The authors consider these dots as autophagosomes, and argue that their data agree with the findings of a recent Science paper by the Mizushima lab. However, this is not true: the abnormal autophagosome-like structures forming in ATG conjugation gene knockout mammalian cells are negative for LC3 (the homolog of LGG-1), as LC3 does not associate with autophagic structures in the absence of its lipidation. See Figure 4H in Tsuboyama et al., 2016. It is firmly established that Atg8/LGG-1/LC3 lipidation is required for its membrane association in all tested models including yeast, worms and *Drosophila*, not only in mammals. I thus think that an unknown and variable proportion of the mCherry::GFP::LGG-1 dots observed in the various genetic backgrounds represent aggregates of the reporter protein (probably most of it is aggregates in Atg3 mutants), which undermines the validity of the whole study. This is especially true as the data are not verified with a robust independent test, such as endogenous LGG-1 puncta formation -- it is insufficient to show that the overexpressed reporter is positive for anti-LGG-1! The main message of autophagy guidelines papers is to always rely on multiple independent tests when evaluating autophagy, so the revised manuscript still does not meet this fundamental requirement. The authors even cite Klionsky et al. 2016 Autophagy (in which the senior author is a co-author) representing a consensus recommendation of 2467 researchers in the field, and Dr. Hansen should also follow these guidelines. Taken together, the manuscript is solely based on a reporter that I do not think is reliable, so I am strongly against the publication of this preliminary work in any journal.

(Reviewer \#2 corrected his original criticism after he read comments from the other reviewers. Reviewer \#2 thought *atg-3(bp412)* is a genetic null, which led him to conclude that mCherry-GFP-LGG-1 puncta were protein aggregates. Actually, *atg-3(bp412)* is a hypomorphic allele. Genetic nulls for the two conjugation systems in *C. elegans* cause lethality and cannot be tested for this purpose.

This study contains several very interesting points, especially tissue-specific requirement for the longevity conferred by loss of function of *glp-1* and *daf-2*. So my (Reviewing Editor) suggestion is that the authors need test the validity of the reporter. If the authors have the antibodies, those experiments are easy to do.)

*Reviewer \#3:*

The authors have made notable efforts to sufficiently address the issues raised by the reviewers. I have only one remaining issue.

[Figure 7](#fig7){ref-type="fig"} is not necessary as the panels do not really help readers understand their conclusions. The panels are also misleading as they are not actual data but look oversimplified and biased versions of data. I suggest that the authors instead need to draw models that represent their conclusions of the manuscript.

10.7554/eLife.18459.029

Author response

*1) This study relies heavily on the tandem nCherry-gfp-lgg-1 reporter to monitor autophagic flux. It has been shown that overexpressed Atg8/LC3 reporters not only form aggregates but can also label non-autophagic structures (such as the Golgi) in yeast and mammalian cells. Further validation of the tandem reporter using Atg gene mutant backgrounds would be necessary in the different tissues.*

*A) LGG-1/ATG8 must be lipidated in order for it to form punctate structures. The transgenic reporter could be crossed into various autophagy gene mutants that abolish LGG-1 lipidation, including atg-4.1; atg-4.2, atg-16.1; atg-16.2, atg-3, atg7, and then the formation of puncta can be examined. If mCherry-gfp-lgg-1 puncta are absent in those mutants, it indicates that the puncta represent autophagic structures. The expression of this tandem reporter could also be examined in mutants of the Atg1 kinase complex, in which LGG-1 displays a unique distribution pattern at embryonic stages.*

To further validate our new mCherry::GFP::LGG-1 reporter, we have expressed and examined it in *atg-3(bp412)* and *atg-18(gk378)* mutants (we note that we also attempted to introduce the reporter in *atg-4.1(bp411)* and *unc-51(e369)* mutants, yet we were unable to optimize protocols and finalize these crosses in time for resubmission). In embryos, the *atg-3(bp412)* mutant has been reported to lack puncta as detected by using an antibody to label endogenous LGG-1 (Tian et al., 2010). Interestingly, we observed more autophagosomes (AP) and less autolysosomes (AL) in both *atg-3(bp412)* and in *atg-18(gk378)* mutants compared to wild-type (WT) transgenic animals ([Author response image 1A-C](#fig7){ref-type="fig"}). We also found that *atg-18(gk378)* mutants expressing GFP::LGG-1had increased number of GFP-positive punctae (i.e., APs; [Author response image 1D](#fig7){ref-type="fig"} **--** unpublished results, C. Kumsta and M. Hansen). Similarly, we saw APs increase and ALs decrease in WT transgenic animals expressing mCherry::GFP::LGG-1 that were fed bacteria expressing dsRNA for two generations to inhibit *unc-51/atg-1* and *atg-13* (both part of the ATG1 kinase complex) in addition to *bec-1* and *atg-9* (Class II PI3K Complex -- required for vesicle nucleation) and *atg-7* and *atg-18* (required for vesicle elongation to form a puncta) ([Author response image 2](#fig8){ref-type="fig"}). Our data are consistent with recent work from Dr. Noburo Mizushima's lab, which has examined Atg8 conjugation mutants affecting the closure (fission) step such as Atg5, Atg4b, and Atg3. Specifically, they observe that these mutants can form autophagosome-like structures that are labeled with the syntaxin protein Stx17 and can fuse with lysosomes but take \~10x longer to convert to an autolysosome compared to WT (Tsuboyama et al., Science, 2016). This may explain why we observed an increased numbers of APs and decreased ALs in *atg-3(bp412)* and *atg-18(gk378)* mutants expressing the mCherry::GFP::LGG-1 reporter. While we do not know the reason for the observed difference between embryonic and adult LGG-1 puncta numbers in *atg-3(bp412)* mutants, we speculate that it may relate to redundancy in adult functions of this gene.10.7554/eLife.18459.021Author response image 1.*atg-3* and *atg-18* mutants have more APs and less ALs compared to wild type.(**A**) Hypodermal seam cells in wild-type (WT), *atg-3(bp412)* and *atg-18(gk378)* transgenic animals expressing *mCherry::gfp::lgg-1,* imaged using confocal microscopy at Day 1 of adulthood. (B-C) Quantification of autophagosomes (AP) and autolysosomes (AL) in hypodermal seam cells (**B**) and intestine (**C**) of adult Day 1 WT, *atg-3(bp412)*, and *atg-18(gk378)* animals expressing *mCherry::gfp::lgg-1*. Data are the mean ± SEM of ≥29 animals combined from three experiments. \*\*\*\*p\< 0.0001 by ANOVA. (**D**) Hypodermal seam cells in WT and *atg-18(gk378)* transgenic animals expressing *gfp::lgg-1* imaged using Zeiss apotome at Day 1 of adulthood. Data courtesy of Dr. Caroline Kumsta, Hansen lab.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.021](10.7554/eLife.18459.021)10.7554/eLife.18459.022Author response image 2.Quantification of autophagosomes and autolysosomes following inhibition of early autophagy genes using RNAi.(**A**, **B**) Quantification of autophagosomes (AP) and autolysosomes (AL) in hypodermal seam cells (**A**) and intestine (**B**) of adult Day 1 wild-type animals expressing *mCherry::gfp::lgg-1* fed for two generations with bacteria expressing control (empty vector) or *atg-1, atg-7, atg-9, atg-13, atg-18* or *bec-1* dsRNA. Data are the mean ± SEM of ≥28 animals combined from three experiments. \*\*\*\*p\< 0.0001, \*\*p\<0.005, \* p\<0.05 to WT control by ANOVA.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.022](10.7554/eLife.18459.022)

*B) Endogenous LGG-1, detected by anti-LGG-1, could be used to demonstrate the change in autophagy activity in aged animals.*

We agree with the reviewer that detection of endogenous LGG-1 would be a useful way to further validate the new tandem reporter. We recently developed a new LGG-1 antibody that we have so far only used for Western blotting ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We have now optimized the use of this antibody for immunofluorescence in dissected intestines of adult animals. Using our protocol/antibody, we have determined that GFP and mCherry both co-localize with anti-LGG-1, confirming that the tagged version is labeling LGG-1 positive puncta, at least in the intestine (new [Figure 1---figure supplement 1D, E](#fig1s1){ref-type="fig"}). We have discussed these new data, where we say:

"Moreover, immunofluorescence analysis of the intestine of mCherry::GFP::LGG-1-expressing animals showed that both GFP- and mCherry-positive punctae co-localized with structures stained by an LGG-1 antibody ([Figure 1---figure supplement 1D, E](#fig1s1){ref-type="fig"})."

We also describe these data in the figure legend of [Figure 1---figure supplement 1D, E](#fig1s1){ref-type="fig"} where we say:

"(D-E) Immunofluorescence to detect endogenous LGG-1 (green) and GFP (D; red) or mCherry (E; red) in dissected intestines of wild-type (WT) animals. Data representative of ≥ 2 experiments (N ≥ 5 animals in each). Scale bars = 20 µM."

Additionally, we describe our antibody immunofluorescence protocol in the Methods section, where we say:

"*Immunofluorescence of C. elegans intestines*

Day 1 adult transgenic animals expressing *mcherry::gfp::lgg-1* were picked into a drop of M9 on a glass slide and dissected by pulling the head and tail apart with forceps resulting in the intestine popping out of the animal. \[...\] N2/WT animals treated with secondary antibodies only did not show fluorescence staining in the muscle, pharynx or hypodermis demonstrating that fluorescence in transgenic animals is due to the reporter that wasn't quenched during fixation (data not shown)."

While we agree that this technique could be useful to demonstrate changes in autophagy in aged animals, the optimization of this new protocol/antibody proved challenging and time consuming and would have constituted a huge undertaking. Instead, we have stained Day 1 *daf-2* mutants, which appeared to display an increased number of puncta in their intestines compared to WT animals ([Author response image 3](#fig9){ref-type="fig"}), consistent with our detailed quantifications of the fluorescent tandem LGG-1 reporter. Since we have yet to develop the protocol to reliably count punctae from imaged intestine, we prefer to not include these data in the revised manuscript.10.7554/eLife.18459.023Author response image 3.mCherry and GFP co-localize with endogenous LGG-1 in transgenic animals expressing mCherry::gfp::lgg-1.(**A-B**) Immunofluorescence to detect endogenous LGG-1 (green, rabbit anti-LGG-1 antibody made by Abgent) and GFP (A; red, mouse anti-GFP from Santa Cruz Biotechnology) or mCherry (B; red, mouse anti-mCherry from Clonetech) in dissected intestines of wild-type (WT, top, data also in [Figure 1---figure supplement 1D, E](#fig1s1){ref-type="fig"}) or *daf-2(e1370)* animals (bottom). Data representative of ≥2 experiments (N≥5 animals in each). Scale bars = 20 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.023](10.7554/eLife.18459.023)

*2) The authors show that autophagy in hypodermal seam cells is induced in daf-2 mutants but blocked in germline-less glp-1 mutants. However, the numbers of APs and ALs are pretty low in this tissue in wild type and mutant animals with or without Bafilomycin treatment. Other assays such as degradation of the well-characterized autophagy substrate SQST-1 in partial loss-of-function autophagy mutants need be performed to demonstrate the differential autophagy activity in daf-2 and glp-1 mutants.*

It is indeed interesting, but perhaps not surprising that hypodermal seam cells have "lower" number of APs and ALs in both WT and mutant animals with or without BafA treatment compared to other tissues since their cell size is much smaller than the regions quantified in other tissues. That said, we agree with the reviewer that examination of SQST-1 punctae in WT animals versus *daf-2* and *glp-1* mutants would be informative. To address this point, we used a novel *sqst-1p::sqst-1::gfp* reporter (the expression profile of these animals were equivalent to a previously published *sqst-1p::sqst-1::gfp* strain from Hong Zhang's lab, data not shown), which we crossed to *glp-1(e2141)* and *daf-2(e1370)* mutants. When we analyzed Day 1 animals in their head region where the expression of this reporter is most prominent in adult animals ([Author response image 4A-D](#fig10){ref-type="fig"}), we found that *glp-1* mutants had similar numbers of SQST-1 punctae to WT animals, whereas *daf-2* animals had fewer punctae compared to WT animals ([Author response image 4E-F](#fig10){ref-type="fig"}). BafA treatments potently increased punctae in *daf-2* animals, consistent with enhanced autophagic activity between the two pharyngeal bulbs in *daf-2* mutants ([Author response image 4C-F](#fig10){ref-type="fig"}). Similarly, BafA treatment also increased punctae in *glp-1* mutants compared to WT. However, this region likely consists mostly of neurons, and any hypodermal seam cells are difficult to see and distinguish from the ventral/dorsal nerve cord in this strain ([Author response image 4A-D](#fig10){ref-type="fig"}). Thus, we would like to refrain from making any conclusions in regards to the hypodermal seam cells with this novel SQST-1 reporter, and although we tried, we have not been successful in making a useful reporter expressing SQST-1 from hypodermal promoters for this resubmission.

Instead, we have expanded our analysis of seam cells by analyzing *daf-2* and *glp-1* mutants in which we inhibited autophagy by *rab-7* or control (empty vector) RNAi from hatching. Consistent with active autophagy in the hypodermal seam cells of *daf-2* mutants, inhibition of *rab-7* resulted in an further increase in APs and ALs, while *glp-1* mutants showed no change in APs and ALs following *rab-7* inhibition (included as new [Figure 2---figure supplement 3D, E](#fig2s3){ref-type="fig"}), suggesting a block of autophagy as our original BafA data indicated. We have inserted a comment about this additional experiment, where we say:

"We observed similar results when we blocked autophagy by *rab-7* RNAi ([Figure 2---figure supplement 3D, E](#fig2s3){ref-type="fig"})."10.7554/eLife.18459.024Author response image 4.The number of SQST-1/p62 puncta is decreased in *daf-2* animals compared to wild type.(**A**, **B**) Whole-body expression of new *sqst-1p::sqst-1::gfp* reporter in a wild-type (WT) animal at Day 1 of adulthood. Scale bar = 200 µm. Overlay of GFP and bright-field images (**A**) and GFP only (**B**). (**C**, **D**) Images of the head region quantified (between pharyngeal bulbs indicated by dotted lines) in WT animals treated with DMSO (**C**) or BafA (**D**). AB = anterior bulb; TB = terminal bulb. Scale bar = 20 µM. (**E**, **F**) Quantification of the number of SQST-1::GFP puncta in *daf-2(e1470)* and WT animals raised at 20^o^C (**E**) or *glp-1(e2141)* and WT animals raised at 25^o^C (**F**) and injected with DMSO or BafA at Day 1 of adulthood. Data are the mean ± SEM of ≥30 animals combined from three experiments. \*\*\*\*p\< 0.0001, \*\*p\<0.005, \* p\<0.05 by ANOVA.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.024](10.7554/eLife.18459.024)

*3) Bafilomycin treatment was used to block lysosome degradation in this study. However, Bafilomycin was administered by injection, which may result in variation among animals.*

We are aware that such variability could exist in the Bafilomycin A (BafA) injection assay (which we developed to minimize the time to reach steady-state conditions (2 hrs)). However, we argue that such variability does not significantly affect our interpretations for multiple reasons. First, we injected Texas Red Dextran (5000 Daltons, i.e., significantly larger than BafA) into a large number of worms (\~100) to determine reproducibility of injection. In the head region, where we quantified punctae in all assays, we saw a highly reproducible Texas Red Dextran signal ([Author response image 5](#fig11){ref-type="fig"}). Second, we note that the standard error of the mean is similar in DMSO and in BafA-treated animals in each of our many performed experiments (as well as in published work, see Wilkinson et al., Molecular Cell, 2015), suggesting that any variability in the number of punctae is likely due to variability per animal rather than variable injection of BafA. We have made a comment to this experimental point in the Methods, where we say:

"Injection of BafA could result in variability of LGG-1 punctae counts, however, injection of a Texas Red Dextran (5,000 Daltons, i.e., significantly larger than BafA) into \~100 worms showed highly reproducible Texas Red signal in the head region where LGG-1 punctae were quantified (data not shown), and the standard error of the mean is similar in DMSO- and in BafA-treated animals in all experiments performed (as well as in published work see (Wilkinson et al., 2015)). Thus, notable variability in number of punctae is likely due to variability per animal rather than variable injection of BafA."10.7554/eLife.18459.025Author response image 5.Texas Red Dextran injections are very reproducible.(**A**, **B**) Injection of Texas Red Dextran (5000 Daltons) into wild-type (WT) animals. Images (8x magnification) from 2 experiments (A and B) with 50 injected animals analyzed 10 at a time (i.e., 5 panels of 10 animals) per experiment. Top row = Brightfield, middle row = 0.25 second exposure, bottom row = 1 second exposure. Scale bars = 200 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.025](10.7554/eLife.18459.025)

*Genetic mutants with impaired lysosomal function, including cup-5 and laat-1, could be used to follow the number of APs and ALs in aged animals or long-lived mutants.*

Throughout the study, we have blocked autophagy by using adult-only autophagy gene RNAi and short-term (2 hour) BafA treatments to avoid contributions of developmental autophagy. Therefore using genetic mutants to assess lysosomal function in aged animals is not an ideal experiment (plus such mutants were not currently available through the *C. elegans* stock center). The best experiment would be to use adult-only RNAi, but it is difficult to induce changes in fluorescent LGG-1 reporters with adult-only RNAi treatments (Hansen et al., PLOS Genetics, 2008). That said, we agree with the reviewer that it would be interesting to further investigate the effects of blocking lysosomal function (noting that BafA was used to block lysosomal acidification). To this end, we fed bacteria expressing dsRNA for the two lysosomal genes *laat-1* and *cup-5* to animals expressing mCherry::GFP::LGG-1 for two generations, and analyzed these animals on Day 1 of adulthood. This analysis showed increases in APs (hypodermal seam cells and intestine) and decreases in ALs in the intestine and pharynx, but not in hypodermal seam cells and in muscle ([Author response image 6](#fig12){ref-type="fig"}). While the differences between tissues at this point remain unclear, these data are overall consistent with a decrease in autophagic activity at Day 1 of adulthood following inhibition of *laat-1* and *cup-5.*10.7554/eLife.18459.026Author response image 6.Quantification of autophagosomes and autolysosomes following Inhibition of lysosomal genes *cup-5* and *laat-1*.(**A-D**) Quantification of autophagosomes (AP) and autolysosomes (AL) in hypodermal seam cells (**A**), intestine (**B**), pharynx (**C**), and muscle (**D**) of adult Day 1 wild-type (WT) animals expressing *mCherry::gfp::lgg-1* fed for two generations with bacteria expressing empty vector (control) or *cup-5* or *laat-1* dsRNA. Data are the mean ± SEM of ≥45 animals combined from three experiments. \*\*\*\*p\< 0.0001, \*\*p\<0.005, \*p\<0.05 by ANOVA.**DOI:** [http://dx.doi.org/10.7554/eLife.18459.026](10.7554/eLife.18459.026)

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:*

*Other assays are needed to demonstrate that mCherry::GFP::LGG-1 puncta are autophagic structures but not protein aggregates.*

We have made a number of experimental and textual changes to address the reviewer's remaining concerns. While further validation of the tandem reporter is possible, yet technically challenging (see below), we have instead reorganized our revised manuscript to better emphasize data with the well-established GFP::LGG-1 reporter (new [Figure 1](#fig1){ref-type="fig"}). To further increase confidence in this reporter, we have analyzed a lipidation-deficient GFP::LGG-1(G116A) reporter (Manil-Segalen et al., Developmental Cell, 2014). Specifically, we show that no or few punctae are formed over time in the intestine, body-wall muscle, and pharynx of WT, *daf-2,* or *glp-1* animals expressing GFP::LGG-1(G116A) (new [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), arguing that GFP::LGG-1 punctae represent autophagosomes (APs) and do not seem to form aggregates with age in these tissues.

Unexpectedly, we observed GFP::LGG-1(G116A) punctae in hypodermal seam cells of *glp-1* mutants (former [Figure 4](#fig4){ref-type="fig"}, now Figure 4---figure supplement 9E), indicating that GFP::LGG-1 may aggregate in this cell type. Likewise, we observed GFP::LGG-1(G116A) punctae in *atg-3(bp412)* and *atg-18(gk378)* autophagy mutants (newFigure 4---figure supplement 9H-I, and data not shown, see also response to reviewer \#1 below), similar to observations in mammalian Atg5 knockout cells overexpressing GFP::Atg8/LC3 (Kuma *et al.*, Autophagy, 2007). Collectively, these findings emphasize the importance of using a GFP::LGG-1(G116A) reporter to help assess whether GFP::LGG-1 punctae are likely to represent APs in any given context. We have therefore excluded the *daf-16* data set presented in the Discussion of the previous manuscript (revision 1), while analysis of *daf-16;* GFP::LGG-1(G116A) mutants are underway. Overall, we appreciate the opportunity to carry out these important control experiments, as they constitute a significant advance in the field.

While we recognize the usefulness of a similar mCherry::GFP::LGG-1 lipidation mutant, we were unsuccessful in creating such a new reporter in the resubmission period. However, we remain confident that the new tandem-tagged reporter reliably monitors APs and autolysosomes (AL) in *C. elegans* for multiple reasons. Specifically, we show (1) mCherry::GFP::LGG-1 is full length ([Figure 2---figure supplement 2A-C](#fig2s2){ref-type="fig"}), and (2) is able to rescue a lethal *lgg-1* null mutant (data not shown), that (3) AP numbers with and without BafA treatment are similar in essentially every tissue and stage of adulthood between the well-established GFP::LGG-1 reporter and the new mCherry::GFP::LGG-1 reporter ([Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}--[5](#fig5){ref-type="fig"} and Figure 3---figure supplement 8, Figure 4---figure supplement 94*daf-2,* and *glp-1* animals ([Figure 2H-I](#fig2){ref-type="fig"}), that (5) inhibition of AP conversion by *rab-7* RNAi ([Figure 2K](#fig2){ref-type="fig"}) decreases ALs in the intestine of Day 1 WT animals, that (6) a *cst-1/Stk4* hippo kinase mutant with blocked autophagy does not respond to BafA (Figure 2---figure supplement 5C), and finally, as shown previously ([Author response image 4](#fig10){ref-type="fig"}, see previous response to reviewers), (7) we observed that Day 1 *daf-2* mutants had fewer SQST-1::GFP punctae compared to WT, consistent with increased autophagy and conclusions made using the new tandem reporter. Irrespective of these lines of evidence, we acknowledge that we cannot fully account for 15% red-only punctae ([Figure 2I](#fig2){ref-type="fig"}). These punctae could represent aggregates, or, alternatively, inefficient Lysotracker staining (as noted in the original and current manuscript). While we at present cannot distinguish between these possibilities, this estimate does not significantly offset any of our conclusions, and we observe similar% red-only punctae between genotypes (new Figure 2---figure supplement 5D).

To fully recognize this limitation and that our validation of the tandem-reporter was primarily done in the intestine of young WT animals, we have revisited our conclusions so they are based on consistent results between the mCherry::GFP::LGG-1 and GFP::LGG-1 reporters, or with clear note of limitations if a possible conclusion is suggested from AL counts only. Lastly, we have expanded the Discussion to carefully discuss the limitations of the reagents used in our study, including the need to fully evaluate neurons with an LGG-1(G116A) reporter (as the existing reporter did not allow accurate identification of neurons, see figure legend to new [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Our conclusions remain unchanged overall, except for *glp-1* hypodermal seam cells (as noted above), and the muscle analysis of young *glp-1* animals, in which the flux analysis of the GFP::LGG-1 and mCherry::GFP::LGG-1 reporters, for unknown reasons, gave variable results in this one case ([Figure 5B](#fig5){ref-type="fig"} and Figure 3---figure supplement 8F'). While these two cases represented novel examples of a potential autophagy block in a long-lived animal, we note that our data set still reports on an example of a block of autophagy in a long-lived mutant, namely in the pharynx of young *daf-2* mutants. To reflect this change, we no longer explicitly highlight potential autophagy blocks in the abstract, but discuss appropriately in the main text.

Overall, we conclude that our revised manuscript, despite its noted limitations, represents a significant advance of our ability to measure autophagy in a multi-cellular organism, as well as our understanding of the role of autophagy during aging, and it provides an important new tool for the *C. elegans* field to be further validated in the future.

*Anti-LGG-1 antibody could be used to detect endogenous LGG-1 (not in animals carrying the transgene) pattern in larvae.*

We would like to clarify that we carried out LGG-1 antibody staining in transgenic animals since it was important to verify that mCherry::GFP::LGG-1 positive punctae were positive for both fluorophores as well as LGG-1, i.e., to argue that full-length protein was present in these punctae. We have made this point clearer in the resubmitted manuscript by moving the comment to page 8 as an introductory comment. That said, we recognize that staining for endogenous LGG-1 in the intestine (the only tissue we are capable of performing immunohistochemistry in adult animals at this point) would be useful to confirm differences observed with the fluorescent LGG-1 reporters of WT and long-lived mutants (while noting that this approach cannot differentiate the AP and AL compartments, as a mCherry::GFP::LGG-1 reporter is expected to do, nor would it allow to conclude if a positive structure is an aggregate or a *bona fide* autophagic vesicle). During the resubmission period, we therefore set out to antibody stain non-transgenic N2 WT and long-lived mutants. For these efforts, we had to use a new batch of the LGG-1 antibody that we previously obtained from Abgent, but this reagent unexpectedly resulted in Western blots of much reduced quality (data not shown), and we have been unable to carry out additional immunohistochemistry experiments.

That said, we note that we indeed stained N2 WT animals in our LGG-1 immunostainings for the original submission, and observed LGG-1-positive punctae in these animals, as expected ([Author response image 7](#fig13){ref-type="fig"}).10.7554/eLife.18459.027Author response image 7.Antibody staining in N2 (Wild Type) animals.(**A-B**) Day 1 WT animals stained with rabbit anti-LGG-1 (green middle) and either mouse anti-mCherry (**A**), or mouse anti-GFP (**B**) (which here functioned as negative controls). Secondary antibody control had no fluorescence in either green or red channels (data not shown). Left column is merged image DIC, anti-LGG-1 and anti-mCherry or anti-GFP, middle is anti-LGG-1 only (green), and right is either anti-mCherry (**A**) or anti-GFP (**B**). Data representative of one experiment (N≥5 animals in each condition).**DOI:** [http://dx.doi.org/10.7554/eLife.18459.027](10.7554/eLife.18459.027)

*SQST-1 could also be stained to see whether it is colocalized with mCherry::GFP::LGG-1 puncta (three color staining).*

We thank the editor for this suggestion, but we do not have access to an SQST-1 antibody. While an interesting experiment, it may, however, not be fully conclusive for the following reason. We have done co-localization assays of an unpublished TOMATO::LGG-1 strain from our lab and SQST-1::GFP (HZ589). While we observed frequent co-localization, we detected multiple examples of punctae positive for SQST-1 but not LGG-1, and vice versa (CK and MH, unpublished results). This is to be expected, since LGG-1 could be recruiting different adaptors, and SQST-1 may not always be targeted for autophagic degradation. Moreover, a co-localization event would not conclusively argue for autophagy as aggregated LGG-1 could potentially bind to SQST-1 even though it may not yet have been destined for autophagic degradation.

In conclusion, believe that the best experiment to do would be to co-stain with another membrane marker (i.e., Atg5 before closure, or Syntaxin-17 after closure of the autophagic vesicle), yet such reagents are, to our knowledge, unfortunately not currently available in the *C. elegans* field.

Reviewer \#1:

*The authors have addressed many of my concerns. But they need clarify/address the following remaining concerns:*

*1) atg-3(bp412) is not a null allele. Genetic nulls for two conjugation systems are lethal. Thus, alternative explanation for the formation of LGG-1 puncta in atg-3(bp412) larvae need be discussed.*

We thank the reviewer for having us revisit the *atg-3(bp412)* mutant, which we showed in the previous response to the reviewers displayed increased AP and decreased AL numbers in hypodermal seam cells and in the intestine of young adults expressing the tandem reporter ([Author response image 1](#fig7){ref-type="fig"}; similar observations were made with *atg-18(gk378)* and multiple autophagy gene RNAi clones in [Author response image 2](#fig8){ref-type="fig"}, see previous response to reviewers). Since *atg-3(bp412)* (and the other conditions we tested) are hypomorphic, we reasoned that AP-like structures could still be formed but were delayed, similar to recent work from Dr. Mizushima's lab (Tsuboyama et al., Science, 2016). However, as noted above, we have now created and analyzed *atg-3(bp412)* mutants expressing the GFP::LGG-1(G116A) lipidation mutant and find many punctate structures in these animals (new Figure 4---figure supplement 9H, and data not shown). We observed similar results when analyzing the *atg-18(gk368)* mutants (new Figure 4---figure supplement 9I, and data not shown). These observations instead argue for possible aggregation events in these mutants, similar to mammalian Atg5 knockout cells which accumulate GFP::Atg8/LC3 in punctate structures shown to be inclusion bodies (Kuma et al., Autophagy, 2007). As noted above, we have now included the hypodermal seam cell counts of these animals as new data in the manuscript,

*2) The authors performed immunostaining against endogenous LGG-1 in animals carrying the mCherry::gfp::lgg-1 transgene. The antibody for sure will recognize MCHERRY::GFP::LGG-1 expressed from the transgene. Such experiments should be carried out in animals without carrying the transgene.*

Please see response to editor above.

Reviewer \#2:

*In their revised manuscript, the authors test the punctate distribution of their new mCherry::GFP::LGG-1 reporter in various Atg loss-of-function backgrounds to validate its use for the analysis of autophagic activity. As expected, they show that the number of mCherry-positive, GFP-negative dots (autolysosomes) decreases in these situations. However, surprisingly, the number of structures positive for both mCherry and GFP increases upon loss of Atg genes such as Atg3 that is required for LGG-1 lipidation and membrane association. The authors consider these dots as autophagosomes, and argue that their data agree with the findings of a recent Science paper by the Mizushima lab. However, this is not true: the abnormal autophagosome-like structures forming in ATG conjugation gene knockout mammalian cells are negative for LC3 (the homolog of LGG-1), as LC3 does not associate with autophagic structures in the absence of its lipidation. See [Figure 4H](#fig4){ref-type="fig"} in Tsuboyama et al., 2016. It is firmly established that Atg8/LGG-1/LC3 lipidation is required for its membrane association in all tested models including yeast, worms and Drosophila, not only in mammals. I thus think that an unknown and variable proportion of the mCherry::GFP::LGG-1 dots observed in the various genetic backgrounds represent aggregates of the reporter protein (probably most of it is aggregates in Atg3 mutants), which undermines the validity of the whole study.*

As stated in the response to editor above, we recognize the limitations of the new tandem-LGG-1 reporter, and have reorganized the manuscript to better emphasize the GFP::LGG-1 data set. Moreover, we have clearly discussed the need for further investigation of the mCherry::GFP::LGG-1 reporter, including validation of this reporter at older age, as well as analyses of G116A mutant versions expressed from endogenous and neuronal promoters (see Discussion of revised manuscript).

As also stated above, we show that no or few GFP punctae are formed over time in the major tissues of WT, *daf-2,* or *glp-1* animals expressing GFP:LGG-1(G116A) (new [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), arguing that GFP::LGG-1 punctae represent autophagosomes (APs) and not aggregates. Unexpectedly, we observed GFP::LGG-1(G116A) punctae in hypodermal seam cells of *glp-1* mutants (former [Figure 3](#fig3){ref-type="fig"}, now Figure 4---figure supplement 9), indicating that GFP::LGG-1 may aggregate in this cell type. Likewise, we observed GFP::LGG-1(G116A) punctae in *atg-3(bp412)* and *atg-18(gk378)* autophagy mutants (new Figure 4---figure supplement 9, and data not shown), similar to observations in mammalian Atg5 knockout cells overexpressing GFP::Atg8/LC3 (Kuma et al., Autophagy, 2007). Collectively, these findings further validate the GFP::LGG-1 reporter and increase confidence in the GFP::LGG-1 data set, but also emphasize the use of a GFP::LGG-1(G116A) reporter to help assess whether GFP::LGG-1 punctae could represent APs in any given context.

While a similar mCherry::GFP::LGG-1 lipidation mutant will be important to create and analyze going forward, we note that our data set is overall very consistent between the GFP::LGG-1 reporter and the AP counts with the new mCherry::GFP::LGG-1 reporter. Regarding the latter, we agree that additional analysis of the red compartment is necessary, in particular since we cannot fully account for 15% red-only punctae ([Figure 2**I**](#fig2){ref-type="fig"}), as also stated above. To this end, we have now also estimated this percentage in *daf-2* and *glp-1* animals (new Figure 2---figure supplement 5D), which show similar or smaller% red-only punctae in the intestine of Day 1 adults increasing confidence in our comparisons of the red channel/AL compartment between genotypes.

*This is especially true as the data are not verified with a robust independent test, such as endogenous LGG-1 puncta formation -- it is insufficient to show that the overexpressed reporter is positive for anti-LGG-1!*

As noted in the response to the editor above, we initially carried out LGG-1 antibody staining in transgenic animals since it was important to verify that mCherry::GFP::LGG-1 positive punctae were positive for both mCherry, GFP and LGG-1, i.e., to argue that these punctae contained full-length protein.

*The main message of autophagy guidelines papers is to always rely on multiple independent tests when evaluating autophagy, so the revised manuscript still does not meet this fundamental requirement. The authors even cite Klionsky et al. 2016 Autophagy (in which the senior author is a co-author) representing a consensus recommendation of 2467 researchers in the field, and Dr. Hansen should also follow these guidelines. Taken together, the manuscript is solely based on a reporter that I do not think is reliable, so I am strongly against the publication of this preliminary work in any journal.*

We agree with the reviewer about the importance of using multiple approaches where at all possible to support claims regarding autophagy. For this study, we developed a new tandem-tagged mCherry::GFP:LGG-1 reporter, similar to Atg8 reagents widely used in mammalian cells, that, to our knowledge, have not previously been validated to the extent that we have validated it here in any system (see response to editor above). For this resubmission, we have reorganized our revised manuscript to better emphasize data obtained with the GFP::LGG-1 reporter (new [Figure 1](#fig1){ref-type="fig"}) and we further validated our GFP::LGG-1 data set by analyzing a GFP::LGG-1(G116A) lipidation mutant in all relevant settings (new [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, Figure 4---figure supplement 9D-E, H-I, and data not shown), thus substantially increasing confidence in the GFP::LGG-1 data set. Thus, we have extensively validated the main reagents we used to carry out a comprehensive and unparalleled spatiotemporal analysis of autophagy in a multi-cellularorganism. As clearly noted in the manuscript, we agree that these observations should be confirmed by additional approaches, including by biochemical methodologies (which we are currently developing, but which represent long-term efforts). Indeed, such confirmatory efforts would require extensive assay development and optimization since no alternative assays are currently available to make comprehensive tissue- or whole organism autophagic activity assessments in *C. elegans* (besides the reporters recently developed in Dana Miller's lab (Chapin et al., Aging, 2015); however, these, too, would require further validation, see Discussion for limitations of this reporter).

Still, we attempted to develop an additional assay in the resubmission period to further support our claims about age-related changes in autophagy in *C. elegans*. Specifically, we tried to implement a 'free GFP cleavage' assay using BafA soaking in adult animals followed by Western blotting, similar to previous protocols in mammalian cells (Klionsky et al., Autophagy, 2016). However, our results were unfortunately quite variable between repeats (Y. Yang and MH, unpublished results) and the assay needs further optimization, including finding the minimal saturating BafA concentrations for WT and long-lived mutants (Ni et al., Autophagy, 2016).

Overall, we conclude that we have done everything reasonably possible to validate the reagents we used in this study, and we would at this point prefer to share them and our comprehensive autophagy analysis during *C. elegans* aging with the research community, while clearly listing the limitations of our study.

*(Reviewer \#2 corrected his original criticism after he read comments from the other reviewers. Reviewer \#2 thought atg-3(bp412) is a genetic null, which led him to conclude that mCherry-GFP-LGG-1 puncta were protein aggregates. Actually, atg-3(bp412) is a hypomorphic allele. Genetic nulls for the two conjugation systems in C. elegans cause lethality and cannot be tested for this purpose.*

*This study contains several very interesting points, especially tissue-specific requirement for the longevity conferred by loss of function of glp-1 and daf-2. So my (Reviewing Editor) suggestion is that the authors need test the validity of the reporter. If the authors have the antibodies, those experiments are easy to do.)*

Please see response to editor above.

Reviewer \#3:

*The authors have made notable efforts to sufficiently address the issues raised by the reviewers. I have only one remaining issue.*

*[Figure 7](#fig7){ref-type="fig"} is not necessary as the panels do not really help readers understand their conclusions. The panels are also misleading as they are not actual data but look oversimplified and biased versions of data. I suggest that the authors instead need to draw models that represent their conclusions of the manuscript.*

We agree with the reviewer and have removed the model figure from the manuscript.
